Pain-Poisoning 2015-2020

STUDIES ON CONDITIONS and RELATED ARTICLES 2015-2020

*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000-2009 List
^Articles/Studies in 2010-2014 List
>Information in Another Section

PAIN*+
PALLIATIVE CARE

PANCREAS/PANCREATITIS+
>PANHYPOPITUITARISM (See News Articles 2010-2018)
PANIC ATTACKS/PANIC
PARANEOPLASTIC CEREBELLAR DEGENERATION/PCD (Autoimmune Condition, Occurs in <1% of Cancer Patients, Causing Gait Problems, Nystagmus and Other Neurological Symptoms)
PARENTING/PARENTS/FAMILY
PARATONIA (Inability to Relax Muscles Which Exhibit Resistance in Response to Passive Movement)

PARKINSON’S DISEASE*+
PATENTS RELATED TO CANNABIS*+
PERINATAL ASPHYXIA (Brain Damage Due To A Lack Of Oxygen During Birth)
PERINATAL HYPOXIC-ISCHEMIC INJURY (Stroke in Infants, See Also STROKES)
PERIPHERAL NERVOUS SYSTEM (All of Your Nervous System That isn’t Your Spine or Brain)

PHANTOM LIMB SYNDROME+ (See News Articles 2010-2018, See Also NEUROPATHIC PAIN)
PHARC/POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA and CATARACT SYNDROME
PHOTOBIOMODULATION/LOW LEVEL LASAR THERAPY (LLLT) (Light Therapy Using  Lasers or LEDs to Improve Tissue Repair, Reduce Pain, etc)
PKAN/PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION/HALLERVORDEN-SPATZ SYNDROME (Genetic degenerative disease of the brain that can lead to parkinsonism, dystonia, dementia and death)
PLACEBO EFFECT
+

POISONING-HEAVY METAL*+
POISONING-ORGANOPHOSPHATE+
POISONING-OTHER
POISONING-PARAQUAT*+^
POISONING–ROTENONE
top


PAIN*+
Aging & Medical Marijuana. (USA) (booklet – undated) https://www.safeaccessnow.org/aging
Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice. (USA) (full – 2015) http://jpet.aspetjournals.org/content/353/2/424.full.pdf+html
Medicinal cannabis. (Australia) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674028/
Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice. (USA) (full – 2015) http://jpet.aspetjournals.org/content/354/2/111.full
The Use of Marijuana and Hydroxyurea Among Sickle Cell Patients. (USA) (full – 2015) http://www.bloodjournal.org/content/128/22/5913?sso-checked=true
Selective Reduction of THC’s Unwanted Effects through Serotonin Receptor Inhibition. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497641/
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440298/
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446380/
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284516/
Coadministration of indomethacin and minocycline attenuates established paclitaxel- induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors. (Kuwait) (full – 2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome. (Canada) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277530/
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (Spain/ France/ USA) (full – 2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity. (Ireland) (full – 2015) http://ijnp.oxfordjournals.org/content/early/2015/09/04/ijnp.pyv095.long
The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons. (Germany) (full – 2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002286
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials. (Canada) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/
Deficiency of G-protein coupled receptor 40, a lipid-activated receptor, heightens in vitro- and in vivo-induced murine osteoarthritis. (France) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935402/
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec. (Canada) (full – 2015) http://cmajopen.ca/content/3/2/E251.full?sid=139f05c1-b441-476b-99ff-addf8c918e1a
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. (UK/ Italy/ Netherlands/ Peru/ USA/ Germany) (full – 2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251
Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms. (USA/ Japan) (full – 2015) http://molecularpain.biomedcentral.com/articles/10.1186/s12990-015-0056-8
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. (USA) (full – 2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy. (USA/ France) (full – 2015) http://www.hindawi.com/journals/bmri/2015/506327/
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464808/
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway Underlies Altered Pain Perception in Leptin Signalling Deficiency. (Italy) (full – 2015) http://www.nature.com/npp/journal/v41/n2/full/npp2015173a.html
Endocannabinoids and acute pain after total knee arthroplasty. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299927/
Cannabinoids in the management of chronic pain: a front line clinical perspective. (Canada) (full – 2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0059/jbcpp-2015-0059.xml

top
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain. (Spain) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770330/
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience. (Israel) (full – 2015) http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9- tetrahydrocannabinol in adult rats. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430373/
Sequelae of Cannabis as Medicine. (USA) (full – 2015) http://painmedicine.oxfordjournals.org/content/16/7/1447
Anandamide Depresses Glycinergic and GABAergic Inhibitory Transmissions in Adult Rat Substantia Gelatinosa Neurons. (Japan) (full – 2015) http://file.scirp.org/Html/1-2500613_54452.htm
Use of paracetamol during pregnancy and child neurological development. (Belgium) (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/dmcn.12745/full
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152762/
Fatty acid amide hydrolase inhibitors: a patent review (2009 – 2014). (Italy) (full – 2015) http://www.tandfonline.com/doi/full/10.1517/13543776.2015.1067683
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549715/
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522350/
Molecular Targets of Cannabidiol in Neurological Disorders. (UK) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604182/
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A systematic review of randomized controlled trials. (Canada/ Germany/ USA) (full – 2015) http://onlinelibrary.wiley.com/doi/10.1002/acr.22727/full
Brain Mapping-Based Model of Δ9-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix. (Germany) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832029/
Cannabis in cancer care. (USA/ Spain) (full – 2015) http://escholarship.org/uc/item/6367m6vj#page-1
A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation. (Italy/ USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840092/
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS). (Canada) (full – 2015) http://www.jpain.org/article/S1526-5900(15)00837-8/fulltext
Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684971/
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644500/
Marijuana Legalization: Impact on Physicians and Public Health. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900958/
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors (Serbia) (full–2015) https://journals.lww.com/anesthesia-
analgesia/fulltext/2015/12000/The_Efficacy_of_Eslicarbazepine_Acetate_in_Models.37.aspx?casa_token=rpUU0XYdtkoAAAAA:LdOaF3PQghtr1Ehqbdb49aITP3CMX5XurxLPnScRRmjwBd_k40JuCtVuSHNPw6eSm-gEOoPa33Hx5pFXcev5WuGW
Is cannabis use associated with less opioid use among people who inject drugs? (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509857/
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats. (China) (full – 2015) https://journals.lww.com/anesthesia-analgesia/Fulltext/2016/04000/Low_Dose_Cannabinoid_Type_2_Receptor_Agonist.14.aspx
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004356/
The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueduactal Grey. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518086/
β-caryophyllene-complexed in β-cyclodextrin Produces Antihyperalgesic Activity in Animal Model for Fibromyalgia. (Brazil/ USA) (click “PDF Reader” for full – 2015) https://docksci.com/-caryophyllene-a-dietary-cannabinoid-complexed-with-cyclodextrin-produced-anti-h_5a1de058d64ab2ae880023d3.html
Cannabinoid CB1 receptors mediate the effects of dipyrone. (Brazil) (click “PDF Reader” for full – 2015) https://docksci.com/cannabinoid-cb1-receptors-mediate-the-effects-of-dipyrone_5a7e1bfad64ab20660305784.html
Acupuncture Mechanisms: Anesthesia, Analgesia and Protection on Organ Functions. (China) (link to PDF – 2015) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.732.8262&rank=2&q=cannabinoid&osm=&ossid
The Role of the Brain’s Endocannabinoid System in Pain and Its Modulation by Stress. (Ireland) (link to PDF – 2015) https://www.researchgate.net/publication/297652035_The_Role_of_the_Brain’s_Endocannabinoid_System_in_Pain_and_Its_Modulation_by_Stress
Profiles of medicinal cannabis patients attending compassion centers in Rhode Island. (USA) (link to PDF – 2015) https://www.researchgate.net/publication/272838883_Profiles_of_Medicinal_Cannabis_Patients_Attending_Compassion_Centers_in_Rhode_Island
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials. (Canada) (link to PDF – 2015) https://www.researchgate.net/publication/273888773_Cannabinoids_for_the_Treatment_of_Chronic_Non-Cancer_Pain_An_Updated_Systematic_Review_of_Randomized_Controlled_Trials
Medical Marijuana: Is the Cart Before the Horse? (USA) (link to PDF – 2015)
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain. (Canada/ USA) (download – 2015) https://www.gastrojournal.org/article/S0016-5085(16)34319-0/pdf
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review. (USA/ Italy) (download – 2015) https://www.researchgate.net/profile/Greg_Goddard2/publication/272406849_The_Effectiveness_of_Cannabinoids_in_the_Management_of_Chronic_Nonmalignant_Neuropathic_Pain_A_Systematic_Review/links/565e6aa308aeafc2aac8fa9c.pdf
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review. (USA) (download – 2015) https://rsds.org/wp-content/uploads/2014/12/medical-marijuana-for-trestment-Chronic-Pain-other.pdf
The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats. (Turkey) (link to download–2015) http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=4378&category_id=119&option=com_virtuemart&vmcchk=1&Itemid=1
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence. (USA) (link to download – 2015) oregonpainguidance.org Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility. (Spain/ Portugal) (link to download – 2015) https://www.academia.edu/16821628/Lipid_nanoparticles_as_an_emerging_platform_for_cannabinoid_delivery_physicochemical_optimization_and_biocompatibility
The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat. (Hungary/ Germany) (link to download – 2015) http://publicatio.bibl.u-szeged.hu/6219/1/Nagy-G.%20G.%20Felt%C3%B6lt%C3%A9skor%20gener%C3%A1lt%281%29.pdf
Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists. (Italy) (click “researchgate” for download – 2015) https://scholar.google.com/scholar?q=Modulatory+effects+by+CB1+receptors+on+rat+spinal+locomotor+networks+after+sustained+application+of+agonists+or+antagonists&hl=en&as_sdt=0&as_vis=1&oi=scholart Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains. (Ireland) (click “nuigalway” for download – 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Repeated+forced+swim+stress+differentially+affects+formalin
– evoked+nociceptive+behaviour+and+the+endocannabinoid+system+in+stress+normo-responsive+and+stress+hyper-responsive+rat+strains.++++++++&btnG
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats. (China) (click “cpsorg” for download – 2015) https://scholar.google.com/scholar?q=Tonic+Modulation+of+Nociceptive+Behavior+and+Allodynia+by+Cannabinoid+Receptors+in+Formalin+Test+in+Rats.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Emerging concepts of pain therapy based on neuronal mechanisms. (Germany) (click “kdarrcom” for download – 2015) https://scholar.google.com/scholar?q=%22Emerging+Concepts+of+Pain+Therapy+Based+on+Neuronal+Mechanisms%22&hl=en&as_sdt=0&as_vis=1&oi=scholart Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates. (USA) (article – 2015) http://journalofethics.ama-assn.org/2015/06/pfor2-1506.html
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits. (USA) (Part 2 of 2) (article – 2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
Clinical pharmacology of medical cannabinoids in chronic pain . (France) (abst in English – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26267945
(full in French – 2015 ) https://www.revmed.ch/RMS/2015/RMS-N-480/Cannabinoides-medicaux-dans-les-douleurs-chroniques-aspects-pharmacologiques
Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors. (Iran) (abst – 2015) https://www.sciencedirect.com/science/article/abs/pii/S0006899315005958
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents. (Turkey) (abst – 2015) https://onlinelibrary.wiley.com/doi/abs/10.1111/nmo.12563
Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish. (Brazil) (abst – 2015) https://www.sciencedirect.com/science/article/abs/pii/S0031938415000669
Peripherally Restricted Cannabinoids for the Treatment of Pain. (USA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26497478
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endocannabinoid receptor in the ventral mesencephalon. (Brazil) (abst – 2015) https://www.sciencedirect.com/science/article/pii/S001429991500268X?via%3Dihub
The role of the endocannabinoid system in pain. (Hungary/ UK) (abst – 2015) http://link.springer.com/chapter/10.1007%2F978-3-662-46450-2_7
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release. (China/ USA) (abst – 2015) https://link.springer.com/article/10.1007/s12035-015-9291-2
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children. (Germany) (abst – 2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys. (USA) (abst – 2015) https://www.semanticscholar.org/paper/Cross-tolerance-to-cannabinoids-in-rhesus-monkeys-Gerak-Zanettini/e09e264fa06b61aba86a74c583276b96a1e4ac94 Neuropeptide VF Enhances Cannabinoid Agonist WIN55,212-2-Induced Antinociception in Mice. (China) (abst – 2015) https://www.semanticscholar.org/paper/Neuropeptide-VF-Enhances-Cannabinoid-Agonist-in-Han-Wang/e1acce000d79b0288638f848508223265b70ff05
A 4-Week Pilot Study With the Cannabinoid Receptor Agonist Dronabinol and Its Effect on Metabolic Parameters in a Randomized Trial. (USA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26283236
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors. (Hungary) (abst – 2015) http://www.sciencedirect.com/science/article/pii/S1043661815002583
The long-term functional consequences of acute infectious diarrhea (Canada) (abst–2015) https://www.semanticscholar.org/paper/The-long-term-functional-consequences-of-acute-Cocciolillo-Collins/0a91a2b9a713a79fc04f1873b0f4a4156709a790
Use of Cannabinoids for Spasticity and Pain Management in MS. (USA) (abst – 2015) https://link.springer.com/article/10.1007%2Fs11940-015-0385-y
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice. (Italy/ Germany) (abst – 2015) https://www.semanticscholar.org/paper/Effects-of-metabolites-of-the-analgesic-agent-on-in-Maione-Radanova/a9d08fde16561e34dd35a2f49e15f412db0cce18
Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice. (Turkey) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26206340
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study. (Italy) (abst – 2015) https://www.semanticscholar.org/paper/Efficacy-and-safety-of-nabiximols-(Sativex%C2%AE)-on-in-Ferr%C3%A8-Nuara/3de44eca12cb1f92457e31f6cb0f794056b13763
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord. (China) (abst – 2015) http://link.springer.com/article/10.1007/s10753-015-0168-3
https://www.semanticscholar.org/paper/Intrathecal-Injection-of-JWH-015-Attenuates-Bone-of-Lu-Liu/73f825be7ee251cfa9ce528af161234eb2905c03
Use of medical cannabis to reduce pain and improve quality of life in cancer patients. (Canada) (abst – 2015) http://meetinglibrary.asco.org/content/155674-165
Medical cannabis: considerations for the anesthesiologist and pain physician. (Canada) (full in English, abst in French – 2016) https://link.springer.com/article/10.1007%2Fs12630-016-0598-x
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. (China) (full – 2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=7042&path%5B%5D=20008
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing- Remitting Multiple Sclerosis. (Italy/ Belgium) (full – 2016) http://link.springer.com/article/10.1007/s13311-016-0420-z/fulltext.html
top
δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats. (Brazil) (full–2016) http://www.mdpi.com/2072-6651/8/4/106/htm
A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase (USA) (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956176/
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (Hungary) (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956369/
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939121/
Chest pain, troponin rise, and ST-elevation in an adolescent boy following the use of the synthetic cannabis product K2. (New Zealand) (full – 2016) http://www.annalspc.com/article.asp?issn=0974-2069;year=2016;volume=9;issue=1;spage=79;epage=81;aulast=Zaleta
Expression of the endocannabinoid receptors in human fascial tissue. (Italy) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933831/
Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management. (Poland) (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00257/full
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain. (Canada) (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00304/full
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines. (Canada) (full – 2016) https://www.ncbi.nlm.nih.gov/books/NBK395789/
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling. (Germany/ Belgium) (full – 2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation. (Sweden) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0167965
Paracetamol sharpens reflection and spatial memory: a double-blind randomized controlled study in healthy volunteers. (France) (full – 2016) https://www.dovepress.com/paracetamol-sharpens-reflection-and-spatial-memory-a-double-blind-rand-peer-reviewed-fulltext-article-
DDDT Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719019/
A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems. (Brazil) (full – 2016) https://jvat.biomedcentral.com/articles/10.1186/s40409-016-0091-6
A user’s guide to cannabinoid therapies in oncology. (Canada) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
Comparative antinociceptive effect of arachidonylcyclopropylamide, a cannabinoid 1 receptor agonist & lignocaine, a local anaesthetic agent, following direct intrawound administration in rats. (India) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393085/
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165161/
Combined treatment with morphine and Δ9-tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851324/
Robust anti-nociceptive effects of MAG lipase inhibition in a model of osteoarthritis pain. (UK/ USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056226/
The role of the endocannabinoid system in the brain-gut axis. (Canada/ USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids. (USA/ China) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5082783/
Sex Differences in Cannabinoid-Regulated Biology: A Focus on Energy Homeostasis. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783283/
Differences in Chloride Gradients Allow for Three Distinct Types of Synaptic Modulation by Endocannabinoids. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982905/
Endocannabinoid system: Role in depression, reward and pain control (Review). (China) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042796/
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives. (Poland/ Germany/ USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916644/
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. (Iran) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056566/
Role of cannabinoids in gastrointestinal mucosal defense and inflammation. (Hungary) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333598/
The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats. (Iran) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887712/
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain from Spinal Cord Injury and Disease. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/
β-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic properties. (Poland) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083753/
Sex-dependent effects of cannabis-induced analgesia. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037015/
Use of cannabinoids in cancer care: palliative care. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791145/
Transmission Pathways and Mediators as the Basis for Clinical Pharmacology of Pain. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215101/
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. (USA/ Spain) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289715/
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053858/
Medical Marijuana: Just the Beginning of a Long, Strange Trip? (USA) (full – 2016) https://academic.oup.com/ptj/article/97/2/239/2937746
Pain, Cannabis Species, and Cannabis Use Disorders. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869908/
Opioids Out, Cannabis In Negotiating the Unknowns in Patient Care for Chronic Pain. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332546/
Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation. (USA/ China/ Sweden) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069149/
Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959092/
Pros and cons of medical cannabis use by people with chronic brain disorders (USA) (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652027/
Gonadal hormone modulation of ∆9-tetrahydrocannabinol-induced antinociception and metabolism in female versus male rats. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5195865/
PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase. (Brazil) (full – 2016) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.13448
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users (New Zealand) (full–2016) https://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2016/vol-129-no-1433-22-april-2016/6865

top
Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses. (Australia) (full – 2016) https://physoc.onlinelibrary.wiley.com/doi/full/10.1113/JP272292
Quantification of pain in sickle mice using facial expressions and body measurements. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746724/
Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936272/
Development and Pharmacological Characterization of Selective Blockers of 2- Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain. (Italy/ France/ USA) (full – 2016) https://escholarship.org/uc/item/0nc4z28r
Nabilone for the Management of Pain. (Canada) (full – 2016) https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.1709
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson’s disease. (Israel) (full – 2016) https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejp.942
Peltatoside Isolated from Annona crassiflora Induces Peripheral Antinociception by Activation of the Cannabinoid System. (Brazil) (click “thieme” link for full – 2016) https://scholar.google.com/scholar?cluster=4437553668833967708&hl=en&as_sdt=0,5
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis. (Italy) (click “PDF Reader” for full – 2016) https://docksci.com/elevated-systemic-levels-of-endocannabinoids-and-related-mediators-across-the-me_5a1d94ccd64ab2efb50e484e.html
Behavioral Characterization of Kappa Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats. (USA) (link to PDF – 2016) http://jpet.aspetjournals.org/content/early/2016/11/30/jpet.116.235630.long
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools. (Italy) (link to PDF – 2016) https://www.researchgate.net/publication/309232208_Hemopressin_Peptides_as_Modulators_of_the_Endocannabinoid_System_and_their_Potential_Applications_as_Therapeutic_Tools
Dissecting the signaling pathways involved in the crosstalk between mGlu5 and CB1 receptors. (Brazil) (link to PDF – 2016) http://molpharm.aspetjournals.org/content/early/2016/06/23/mol.116.104372.long
Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and N- acylethanolamine acid amidase inhibitors. (France/ UK) (link to PDF – 2016) https://www.researchgate.net/publication/309366843_Therapeutic_Potential_of_Fatty_Acid_Amide_Hydrolase_Monoacylglycerol_Lipase_and_N-Acylethanolamine_Acid_Amidase_Inhibitors
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study. (Israel/ USA) (link to PDF– 2016) https://www.researchgate.net/publication/295077523_The_Effect_of_Medicinal_Cannabis_on_Pain_and_Quality_of_Life_Outcomes_in_Chronic_Pain_A_Prospective_Open-label_Study
The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice. (Iran/ Canada) (link to PDF – 2016) https://www.researchgate.net/publication/267340017_Influence_of_muscarinic_receptor_modulators_on_interacerebroventricular_injection_of_arachydonylcyclopropylamide_induced_antinociception_in_mice
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases. (Canada/ Germany) (link to PDF – 2016) https://www.researchgate.net/publication/309881162_Cannabinoids_in_the_Management_of_Musculoskeletal_or_Rheumatic_Diseases
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons. (UK) (link to PDF– 2016) https://spiral.imperial.ac.uk:8443/handle/10044/1/43081
Medical cannabis associated with decreased opiate medication use in retrospective cross- sectional survey of chronic pain patients. (USA) (download – 2016) https://www.omofmedicine.org/wp-content/uploads/2018/05/um-om-pain-study.pdf
β-caryophyllene, a dietary cannabinoid, complexed with β-cyclodextrin produced anti- hyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn. (Brazil/ USA) (link to download – 2016) http://menezespp.com/wp-content/uploads/2018/02/17.-Quintans-Jr-b-caripphyllene-2016.pdf
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism. (Ireland) (link to download– 2016) 
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner. (Germany) (click “daneshyari” for download – 2016) https://scholar.google.com/scholar?q=Adolescent+social+rejection+alters+pain+processing+in+a+CB1+receptor+dependent+manner&hl=en&as_sdt=0&as_vis=1&oi=scholart
Cannabinoid pharmacology in cancer research: A new hope for cancer patients? (UK/ Italy) (click “hudacuk” for download – 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabinoid+pharmacology+in+cancer+research%3A+A+new+hope+for+cancer+patients%3F&btnG
Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray. (Taiwan/ USA) (click “usdbiologycom” for download – 2016) https://scholar.google.com/scholar?q=Stress+induces+analgesia+via+orexin+1+receptor-
initiated+endocannabinoid/CB1+signaling+in+the+mouse+periaqueductal+gray.&hl=en&as_sdt=0&as_vis=1&oi=scholart State of the evidence: Cannabinoids and cancer pain-A systematic review. (USA) st (1 page – 2016) https://journals.lww.com/jaanp/Citation/2017/02000/State_of_the_evidence__Cannabinoids_and_cancer.8.aspx
Medical use of cannabis products : Lessons to be learned from Israel and Canada. (Germany) (abst in English & German – 2016) https://link.springer.com/article/10.1007%2Fs00482-015-0083-4
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. (Germany) (abst in English & German – 2016) https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord. (New Zealand) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S0304394015303517
https://www.semanticscholar.org/paper/Effect-of-cannabinoids-on-CGRP-release-in-the-rat-Milne-Ashton/b876db5b6435c90c723611edfeb7776b57d94042
TRPV1-FAAH-COX: The Couples Game in Pain Treatment. (Italy) (abst – 2016) https://www.semanticscholar.org/paper/TRPV1-FAAH-COX%3A-The-Couples-Game-in-Pain-Treatment.-Aiello-Carullo/29c6060b14cfa77b4af2aeafd09fd1d5ec3f2796
CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens . (Iran) (abst – 2016) http://link.springer.com/article/10.1007/s12031-016-0716-9
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders. (Netherlands) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer (Finland/ USA) (abst – 2016) https://journals.lww.com/pain/Abstract/2016/02000/Effect_of_endocannabinoid_degradation_on_pain_.12.aspx
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. (Italy) (abst – 2016) https://www.sciencedirect.com/science/article/pii/S0278584616300069
Dronabinol increases pain threshold in patients with functional chest pain: a pilot double- blind placebo-controlled trial. (USA) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26822791
Cannabinoids: Medical implications. (USA) (abst – 2016) https://www.semanticscholar.org/paper/Cannabinoids%3A-Medical-implications.-Schrot-
Hubbard/2aab2c83e7a45a160550cdad7a2c877e02b2c9cc A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2. (China) (abst – 2016) https://link.springer.com/article/10.1007%2Fs10571-016-0349-0
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats. (UK) (abst – 2016) https://link.springer.com/article/10.1007%2Fs00192-016-2984-x
Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report. (USA) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26956672
Cannabis in Pain Treatment: Clinical & Research Considerations. (USA/ Canada) (abst – 2016) http://www.jpain.org/article/S1526-5900(16)00543-5/fulltext
https://www.semanticscholar.org/paper/Cannabis-in-Pain-Treatment%3A-Clinical-and-Research-Savage-Romero-Sandoval/5c366bb61590d4491e0c181640581d1e8e5105ac Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain. (Italy) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26996621
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy. (China) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27028159
MEDICAL CANNABIS. (Israel) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. (Poland/ Italy) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667
Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance. (Turkey) (abst – 2016) https://www.semanticscholar.org/paper/Changes-in-nociceptin%2Forphanin-FQ-levels-in-rat-and-Ulugol-Topuz/47fe33dc97b739201eca125685f605de8c6344c1
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis. (Italy) (abst – 2016) http://www.msard-journal.com/article/S2211
-0348(16)30056-6/abstract Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia. (USA/ Republic of Korea) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S0361923016301617
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment. (USA) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S0306460316302477
Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats. (Brazil) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1734114016300913
Pain in Extrapyramidal Neurodegenerative Diseases. (Israel) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27623111
Nature of the placebo and nocebo effect in relation to functional neurologic disorders. (Italy) (abst – 2016) https://www.sciencedirect.com/science/article/pii/B9780128017722000485
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine. (China) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27834685
Cannabinoid receptor ligand bias: implications in the central nervous system. (USA/ Canada) (abst – 2016) https://www.sciencedirect.com/science/article/pii/S1471489216301266?via%3Dihub
The central cannabinoid receptor type-2 (CB2) and chronic pain. (China) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27842450
A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence. (USA) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0028390816305226
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis. (abst – 2016) (Canada) http://www.msard-journal.com/article/S2211-0348(16)30171-7/fulltext https://www.semanticscholar.org/paper/Attitudes-to-cannabis-and-patterns-of-use-among-Banwell-Pavisian/d6b1312f0d1dca1ed8eef6859683fb35e9145d41
Pain in amyotrophic lateral sclerosis. (Italy) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27964824
Plasma endocannabinoid behaviour in total knee and hip arthroplasty. (Italy) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28078867

Cannabinoids in Pain Management and Palliative Medicine. (Germany/ Canada) (full in English, link to full in German – 2017) https://www.aerzteblatt.de/int/archive/article?id=193441
The Placebo Effect in Cardiology: Understanding and Using It. (UK/ Canada) (full in English, abst in French – 2017) http://www.onlinecjc.ca/article/S0828-282X(17)31036-X/fulltext
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives. (USA/ UK) (full – 2017) http://meetinglibrary.asco.org/record/140727/edbook#fulltext
Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients. (Italy/ USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449133/
Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats. (Brazil) (full – 2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00391/full
Endocannabinoids Have Opposing Effects On Behavioral Responses To Nociceptive And Non-nociceptive Stimuli. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517658/
Recent advances in understanding and managing cancer pain. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482325/
Understanding Patients’ Process to Use Medical Marijuana: A Southern New Jersey Community Engagement Project. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513646/
Cannabis as a substitute for prescription drugs – a cross-sectional study. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422566/
The Use of Cannabis for Headache Disorders. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436334/
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management. (Israel) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436335/
Cannabis and Pain: A Clinical Review. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549367/
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569620/
Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go? (Germany/ Austria) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388177/
Early blockade of joint inflammation with a fatty acid amide hydrolase inhibitor decreases end-stage osteoarthritis pain and peripheral neuropathy in mice. (Canada) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445456/
N-Arachidonoyl Dopamine Modulates Acute Systemic Inflammation via Nonhematopoietic TRPV1. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544930/
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242409/
Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407663/
Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. (USA) (full – 2017) http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Blockade of Cannabinoid CB1 Receptors in the Dorsal Periaqueductal Gray Unmasks the Antinociceptive Effect of Local Injections of Anandamide in Mice. (Brazil) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632997/
Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritis. (Poland) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573042/
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities. (Germany) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627668/
Cannabis Roots: A Traditional Therapy with Future Potential for Treating Inflammation and Pain. (Canada/ USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628559/
Expert Panel on Understanding Cannabis: Medicine, Society, Government. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657088/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases . (Italy) (full – 2017) http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430528/
Cannabis use in persons with traumatic spinal cord injury in Denmark. (Denmark/UK) (full – 2017) https://www.medicaljournals.se/jrm/content/html/10.2340/16501977-2105
Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed cannabinoids. (USA) (full – 2017) http://casereports.bmj.com/content/2017/bcr-2017-222059.long
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans. (USA) (full – 2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187926
Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies. (Canada) (full – 2017) http://apm.amegroups.com/article/view/16320/18208
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. (USA/ Japan/ Brazil) (full – 2017) https://www.nature.com/articles/s41598-017-17796-y

top
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease. (Australia) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685274/
Pain medication and long QT syndrome. (Austria) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780213/
Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study. (USA) (full – 2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187795
Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease. (USA/ Germany) (full – 2017) https://academic.oup.com/ecco-jcc/article/11/11/1369/3977952
Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain. (USA) (full – 2017) http://journals.sagepub.com/doi/full/
10.1177/1744806917728227 Chronic Pain Patients’ Perspectives of Medical Cannabis. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845915/
The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice. (Spain) (full – 2017) http://www.mdpi.com/1422-0067/18/11/2268/htm
Antihyperalgesic effect of CB1 receptor activation involves the modulation of P2X3 receptor in the primary afferent neuron. (Brazil) (full – 2017) https://www.sciencedirect.com/science/article/pii/S0014299917300407
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain. (Israel) (full – 2017) https://academic.oup.com/painmedicine/article/18/2/294/2924709
Presynaptic and extrasynaptic regulation of posterior nucleus of thalamus. (USA) (full – 2017) https://www.physiology.org/doi/abs/10.1152/jn.00862.2016?url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed Acetaminophen Metabolite N-Acylphenolamine Induces Analgesia via Transient Receptor Potential Vanilloid 1 Receptors Expressed on the Primary Afferent Terminals of C-fibers in the Spinal Dorsal Horn. (Japan) (full – 2017) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=2630694
Acetaminophen Relieves Inflammatory Pain Through CB1 Cannabinoid Receptors in the Rostral Ventromedial Medulla. (Switzerland/ Hungary) (full – 2017) http://www.jneurosci.org/content/38/2/322.long
Age dependent plasticity in endocannabinoid modulation of pain processing through postnatal development. (UK/ Canada) (full – 2017) http://journals.lww.com/pain/Abstract/publishahead/Age_dependent_plasticity_in_endocannabinoid.99170.aspx
Cannabinoid system of dorsomedial telencephalon modulates behavioral responses to noxious stimulation in the fish Leporinus macrocephalus. (Brazil) (full – 2017) https://www.sciencedirect.com/science/article/pii/S0031938417302299
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (Canada) (full – 2017) https://www.jpsmjournal.com/article/S0885-3924(16)30328-1/fulltext
A selective review of medical cannabis in cancer pain management. (Canada) (full – 2017) http://apm.amegroups.com/article/view/16199/18209
Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome. (Italy/ Spain/ France) (full – 2017) https://onlinelibrary.wiley.com/doi/full/10.111
1/apt.13958 The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces analgesia in mice. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715597/
Opioid-sparing Effect of Cannabinoids: A Systematic Review and Meta-analysis. (Australia/ Canada) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520783/
Topical Medical Cannabis (TMC): A new treatment for wound pain-Three cases of Pyoderma Gangrenosum. (photos) (Canada) (full – 2017) https://www.jpsmjournal.com/article/S0885-3924(17)30351-2/fulltext
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719110/
Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561456/
The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice. (USA/ Turkey/ Saudi Arabia) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558428/
Effects of Centrally Administered Endocannabinoids and Opioids on Orofacial Pain Perception in Rats. (Germany/ Poland) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647185/
Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747994/
Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499986/
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence. (USA/ UK) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758437/
Becoming a Medical Marijuana User. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808850/
Smartphone-based ecological momentary assessment (EMA) of alcohol and cannabis use in older adults with and without HIV infection. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920804/
Cannabinoids activate monoaminergic signaling to modulate key C. elegans behaviors. (USA) (full – 2017) http://www.jneurosci.org/content/37/11/2859.long
Contribution of Endocannabinoid Gene Expression and Genotype on Low Back Pain Susceptibility and Chronicity. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671913/
A peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer- induced bone pain. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095738/#__ffn_sectitle
Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? (USA) (full – 2017) https://www.nature.com/articles/npp2017130
The cannabinoid system and pain. (UK/ Ireland/ USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785108/
Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization-Induced Suppression of Excitation in the Anterior Cingulate Cortex. (China) (full -2017) https://academic.oup.com/cercor/article/28/6/2118/3829385
Corrigendum: Chronic Inflammatory Pain Impairs mGluR5-Mediated Depolarization- Induced Suppression of Excitation in the Anterior Cingulate Cortex. (correction -2017) https://academic.oup.com/cercor/advance-article/doi/10.1093/cercor/bhy147/5047028
Inhibition of monoacylglycerol lipase: Another signalling pathway for potential therapeutic targets in migraine? (Italy/ USA) (full – 2017) https://journals.sagepub.com/doi/full/10.1177/0333102417727537?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as Adjunctive Therapy in Advanced Cancer Patients With Chronic Uncontrolled Pain. (USA/ UK/ Germany) (full – 2017) https://www.jpsmjournal.com/article/S0885-3924(17)30465-7/fulltext
Systematic review: interventions for abdominal pain management in inflammatory bowel disease. (UK) (full – 2017) https://onlinelibrary.wiley.com/doi/full/10.1111/apt.14108
AMP-activated kinase and the endogenous endocannabinoid system might contribute to antinociceptive effects of prolonged moderate caloric restriction in mice. (Germany) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5426584/
The cannabinoid CB2 agonist GW405833 suppresses inflammatory and neuropathic pain through a CB1 mechanism that is independent of CB2 receptors in mice. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502377/
The antinociceptive agent SBFI-26 binds to anandamide transporters FABP5 and FABP7 at two different sites. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884075/
Antinociceptive effects of JWH015 in female and male rats. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849479/

Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: impact of drug and fixed-dose ratio. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766417/
Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice. (Brazil) (full – 2017) https://www.sciencedirect.com/science/article/pii/S0014299915001570
Investigation of Diacylglycerol Lipase Alpha Inhibition in the Mouse Lipopolysaccharide Inflammatory Pain Model. (USA) (full – 2017) http://jpet.aspetjournals.org/content/early/2017/10/02/jpet.117.243808.long
Comparison of cannabinoids with known analgesics using a novel high throughput zebrafish larval model of nociception. (Canada) (full – 2017) https://www.intechopen.com/books/recent-advances-in-cannabinoid-research/zebrafish-as-a-high-throughput-in-vivo-model-for-testing-the-bioactivity-of-cannabinoids Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages Dramatically Enhances Selectivity and Efficacy in Vivo. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837917/
Delta-9-tetrahydrocannabinol decreases masticatory muscle sensitization in female rats through peripheral cannabinoid receptor activation (Canada) (click “wiley” for full–2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Delta-9-
tetrahydrocannabinol+decreases+masticatory+muscle+sensitization+in+female+rats+through+peripheral+cannabinoid+receptor+activation.&btnG
An endocannabinoid uptake inhibitor from black pepper exerts pronounced anti- inflammatory effects in mice. (Mexico/ Switzerland) (link to PDF– 2017) http://pubs.acs.org/doi/abs/10.1021/acs.jafc.7b02979
Is cannabis an effective treatment for joint pain? (USA) (link to PDF- 2017) https://www.clinexprheumatol.org/abstract.asp?a=12225
Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat. (USA) (link to PDF – 2017) https://www.researchgate.net/publication/320687020_Anti-migraine_effect_of_9_-tetrahydrocannabinol_in_the_female_rat
Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. (Israel) (link to PDF – 2017) http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=20&page=E755
Clinical Evidence for Utilizing Cannabinoids in the Elderly. (Israel) (link to PDF – 2017) https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination. (Italy) (link to PDF – 2017) https://www.researchgate.net/publication/315799787_Short-Term_Efficacy_of_CBD-
Enriched_Hemp_Oil_in_Girls_with_Dysautonomic_Syndrome_after_Human_Papillomavirus_Vaccination
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications. (Israel) (link to PDF – 2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
N-Acyl amino acids (Elmiric Acids): endogenous signaling molecules with therapeutic potential. (USA) (link to PDF- 2017) http://molpharm.aspetjournals.org/content/early/2017/11/14/mol.117.110841.long
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts. (USA) (link to PDF – 2017) http://pamw.pl/en/issue/article/29067992
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1 simultaneously to modulate colonic motility and visceral sensation in the mouse: A pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT). (Canada/ USA/ Poland/ Italy/ Germany/ Belgium/ France) (link to PDF – 2017) https://www.researchgate.net/publication/318378715_Targeting_fatty_acid_amide_hydrolase_and_transient_receptor_potential_vanilloid1_simultaneously_to_modulate_colonic_motility_and_visceral_sensation_in_the_mouse_A_pharmacological_intervention_with_ N- Salvinorin A reduces neuropathic nociception in the insular cortex of the rat. (Mexico/ USA) (link to PDF – 2017) https://www.researchgate.net/publication/320214727_Salvinorin_A_reduces_neuropathic_nociception_in_the_insular_cortex_of_the_rat
Preferences for Medical Marijuana over Prescription Medications Among Persons Living with Chronic Conditions: Alternative, Complementary, and Tapering Uses. (USA) (link to PDF– 2017) https://www.researchgate.net/publication/320026411_Preferences_for_Medical_Marijuana_over_Prescription_Medications_Among_Persons_Living_with_Chronic_Conditions_Alternative_Complementary_and_Tapering_Uses
Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia. (USA) (link to PDF – 2017) https://www.researchgate.net/publication/315804249_Endocannabinoid_and_Opioid_System_Interactions_in_Exercise-Induced_Hypoalgesia
Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic pain for eleven days. (Spain) (link to PDF – 2017) https://www.researchgate.net/publication/318718405_Single_oral_dose_of_cannabinoid_derivate_loaded_PLGA_nanocarriers_relieves_neuropathic_pain_for_eleven_days
Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases (Italy) (link to PDF–2017) https://www.researchgate.net/publication/313889347_Gut-
brain_Axis_Role_of_Lipids_in_the_Regulation_of_Inflammation_Pain_and_CNS_Diseases Benefits and Harms of Cannabis in Chronic Pain or Post-traumatic Stress Disorder: A Systematic Review. (USA) (link to PDF – 2017) https://www.hsrd.research.va.gov/publications/esp/cannabis.cfm
Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative. (Brazil/ Israel) (link to PDF – 2017) https://www.researchgate.net/publication/318448788_Antinociceptive_effects_of_HUF-101_a_fluorinated_cannabidiol_derivative
Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing. (Netherlands/ Italy) (link to PDF – 2017) https://www.researchgate.net/publication/321688723_Differential_neuromodulatory_role_of_endocannabinoids_in_the_rodent_trigeminal_sensory_ganglion_and_cerebral_cortex_relevant_to_pain_processing
Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve Ligation-Induced Pain in Rats. (Taiwan) (link to PDF – 2017) https://www.researchgate.net/publication/316882096_Continuous_Intrathecal_Infusion_of_Cannabinoid_Receptor_Agonists_Attenuates_Nerve_Ligation-Induced_Pain_in_Rats
Fatty Acid Amide Hydrolase Inhibitor Treatment in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome, an Adaptive Double-Blind Randomized Controlled Trial (Germany/Netherlands/UK/Latvia/Czech Republic/Lithuania/USA Canada) (link to PDF–2017) https://www.researchgate.net/publication/314125974_Fatty_Acid_Amide_Hydrolase_Inhibitor_Treatment_in_Men_With_Chronic_ProstatitisChronic_Pelvic_Pain_Syndrome_An_Adaptive_Double-blind_Randomized_Controlled_Trial
Peripheral inflammation alters N-arachidonoylphosphatidylethanolamine (20:4-NAPE) induced modulation of nociceptive spinal cord synaptic transmission. (Czech Republic/ UK) (link to download – 2017) https://spiral.imperial.ac.uk:8443/handle/10044/1/48351
The effect of medical marijuana laws on the health and labor supply of older adults: Evidence from the Health and Retirement Study. (USA) (link to download – 2017) http://ftp.iza.org/dp10489.pdf
Cannabis, Cannabinoids, and Sleep: a Review of the Literature. (USA) (link to download – 2017) Cannabis, Cannabinoids, and Sleep: a Review of the Literature Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor. (UK) (link to download – 2017) http://eprints.whiterose.ac.uk/113366/
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. (Brazil) (link to download – 2017) Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice. Cannabinoid signaling in health and disease. (Canada) (click “View/Open” for download – 2017) https://tspace.library.utoronto.ca/handle/1807/75838
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management – An overview of systematic reviews. (Germany/ Canada) (click “researchgate” for download – 2017) https://scholar.google.com/scholar?cluster=14327516406392679206&hl=en&as_sdt=0,5&as_vis=1
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep. (USA) (click “komornlaw” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Substitution+of+medical+cannabis+for+pharmaceutical+agents+for+pain%2C+anxiety%2C+and+sleep+&btnG
Nociceptor plasticity: a closer look. (Italy) (click “Research Gate” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Nociceptor+plasticity%3A+A+closer+look.%22&btnG
Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings. (Germany) (click “cedfoundation” for download – 2017) https://scholar.google.com/scholar?q=Current+evidence+of+cannabinoid-
based+analgesia+obtained+in+preclinical+and+human+%09experimental+settings.&hl=en&as_sdt=0&as_vis=1&oi=sch olart Medical Cannabis for Pain: Anecdote or Evidence (USA) (article – 2017) http://www.tandfonline.com/doi/full/10.1080/15360288.2017.1313358
Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy. (Italy) (abst in English & Italian, link to full in Italian – 2017) http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabis-

Therapeutic potential of Cannabis sativa. (Chile) (abst in English, full in Spanish – 2017) http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872017000300010&lng=en&nrm=iso&tlng=en
Role of cannabis in digestive disorders. (USA/ India) (abst – 2017) https://www.semanticscholar.org/paper/Role-of-cannabis-in-digestive-disorders-Goyal-
Singla/232a2b4bf1a1211f32a299f735c94c5e6a272b44 Electroacupuncture Inhibits NLRP3 Inflammasome Activation through CB2 Receptors in Inflammatory Pain. (China/ USA) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0889159117303926?via%3Dihub
Cannabis for Pain and Headaches: Primer. (USA) (abst – 2017) https://link.springer.com/article/10.1007%2Fs11916-017-0619-7
https://www.semanticscholar.org/paper/Cannabis-for-Pain-and-Headaches%3A-Primer.-Kim-Fishman/bebc1e9df306be62c4332f218c91658f9cfc4ea2
The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. (USA) (abst – 2017) http://www.sciencedirect.com/science/article/pii/S0376871617300881
The endocannabinoid system, a novel and key participant in acupuncture’s multiple beneficial effects. (China / USA) (abst – 2017) http://www.sciencedirect.com/science/article/pii/S0149763417301318
TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling. (Ukraine) (abst – 2017) http://www.eurekaselect.com/151829/article
AMPK contributes to aerobic exercise-induced antinociception downstream of endocannabinoids. (Germany) (abst – 2017) http://www.sciencedirect.com/science/article/pii/S0028390817301983
https://www.semanticscholar.org/paper/AMPK-contributes-to-aerobic-exercise-induced-of-King-Himmelreich-M%C3%B6ser/38d3032bd17c54f9e2d406857e9c577dd07262c9 Medical cannabis use among patients with chronic pain in an interdisciplinary pain rehabilitation program: Characterization and treatment outcomes. (USA) (abst – 2017) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30261-6/fulltext
The Cannabis Information Helpline: Assessing Interest in the Medicinal Use of Cannabis in Australia. (Australia) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28557590
Morin Suppresses Astrocyte Activation and Regulates Cytokine Release in Bone Cancer Pain Rat Models. (China) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28618070
Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in those with pancreatic ductal adenocarcinoma. (Italy) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28631495
Administrations of thalidomide into the rostral ventromedial medulla produce antinociceptive effects in a rat model of postoperative pain. (China) (abst – 2017) https://www.semanticscholar.org/paper/Administrations-of-thalidomide-into-the-rostral-in-Yang-Zhang/4882823426e78708f723bcd5a4107400e188e7e7
Perioperative Patient Beliefs Regarding Potential Effectiveness of Marijuana (Cannabinoids) for Treatment of Pain: A Prospective Population Survey. (USA) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28796754
The Role of Nuclear Hormone Receptors in Cannabinoid Function. (Italy/ UK) (abst – 2017) https://www.sciencedirect.com/science/article/abs/pii/S1054358917300364
Cannabinoids and Pain: Sites and Mechanisms of Action. (Poland/ Ireland) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28826543
Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer. (China) (abst – 2017) https://link.springer.com/article/10.1007%2Fs00210-017-1419-7
https://www.semanticscholar.org/paper/Bufalin-attenuates-cancer-induced-pain-and-bone-in-Ji-Liang/e275cca8f13c0a4ebcf1e4baac0223023cb6d73a
Cannabis and Cannabinoids for Chronic Pain. (USA) (abst – 2017) https://link.springer.com/article/10.1007%2Fs11926-017-0693-1
https://www.semanticscholar.org/paper/Cannabis-and-Cannabinoids-for-Chronic-Pain-Romero-Sandoval-Kolano/70553bf4f70581f2730facdc6714503e4f2028b4
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study. (USA) (abst – 2017) https://www.semanticscholar.org/paper/Experts’-perspectives-on-the-role-of-medical-in-A-Braun-Meyer/c4cbc8f2ce1882e34ff2612107648cb0b6397c46
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor. (Japan) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/29017758
System-specific activity in response to Δ9 -tetrahydrocannabinol: A functional magnetic resonance imaging study in awake male rats. (Canada/ USA) (abst – 2017) https://www.semanticscholar.org/paper/System-specific-activity-in-response-to-%CE%949-a-study-Madularu-Yee/ed928d68ed3d0e8197fa4e9f2a565b1d382a7ac5 Increased expression of type 1 cannabinoid (CB1) receptor among patients with rotator cuff lesions and shoulder stiffness. (Taiwan/ China) (abst – 2017) https://www.sciencedirect.com/science/article/abs/pii/S105827461730589X
CB1 Receptors Mediated Inhibition of ATP-Induced [Ca2+]i Increase in Cultured Rat Spinal Dorsal Horn Neurons. (China) (abst – 2017) https://www.semanticscholar.org/paper/CB1-Receptors-Mediated-Inhibition-of-ATP-Induced-in-Long-Lei/d2bb850785e33cf28e41b6ba16f63aaa4f06ba48
Cannabinoids for the treatment of neuropsychiatric symptoms, pain and weight loss in dementia. (Canada) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/29256923
Preserving the independence of people living with multiple sclerosis towards the end of life. (UK) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/29087751
Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana. (Israel) (abst – 2017) https://www.sciencedirect.com/science/article/abs/pii/S0165032716320018?via%3Dihub
Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis. (Poland) (full – 2018) http://www.mdpi.com/1422-0067/19/2/342/htm
The Cannabinoids Δ8THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812319/
Intrathecal morphine administration reduces postoperative pain and peripheral endocannabinoid levels in total knee arthroplasty patients: a randomized clinical trial. (USA) (full – 2018) https://bmcanesthesiol.biomedcentral.com/articles/10.1186/s12871-018-0489-5
Emerging Role of (Endo)Cannabinoids in Migraine. (Finland/ Russia) (full – 2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00420/full
Endocannabinoid System and Migraine Pain: An Update. (Italy/ USA) (full – 2018) https://www.frontiersin.org/articles/10.3389/fnins.2018.00172/full
Cannabis for the Management of Cancer Symptoms: THC Version 2.0? (Spain) (full – 2018) https://www.ncbi.nlm.nih
.gov/pmc/articles/PMC5961457/ Cannabidiol to Improve Mobility in People with Multiple Sclerosis. (USA) (full – 2018) https://www.frontiersin.org/articles/10.3389/fneur.2018.00183/full#B19
Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti- hyperalgesic Effect. (Italy) (full – 2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00249/full
Electroacupuncture Potentiates Cannabinoid Receptor-Mediated Descending Inhibitory Control in a Mouse Model of Knee Osteoarthritis. (China / USA) (full – 2018) https://www.frontiersin.org/articles/10.3389/fnmol.2018.00112/full
Pharmacotherapeutic considerations for use of cannabinoids to relieve pain in patients with malignant diseases. (Republic of Macedonia) (full – 2018) https://www.dovepress.com/pharmacotherapeutic-considerations-for-use-of-cannabinoids-to-relieve–peer-reviewed-fulltext-article-JPR
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain. (Netherlands/ Italy) (full – 2018) https://www.sciencedirect.com/science/article/pii/S0163782717300619?via%3Dihub
Including cannabinoids in the treatment of painful schwannomatosis. (Italy) (full – 2018) https://onlinelibrary.wiley.com/doi/full/10.1002/brb3.1011
Potential of Endocannabinoids to Control Bladder Pain. (USA) (full – 2018) https://www.frontiersin.org/articles/10.3389/fnsys.2018.00017/full
The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors. (Mexico/ Switzerland) (full – 2018) https://www.frontiersin.org/articles/10.3389/fnmol.2018.00180/full
Pain Modulation after Oromucosal Cannabinoid Spray (SATIVEX®) in Patients with Multiple Sclerosis: A Study with Quantitative Sensory Testing and Laser-Evoked Potentials. (Italy) (full – 2018) http://www.mdpi.com/2305-6320/5/3/59/htm
Rates of cannabis use in patients with cancer. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023560/
Priority areas for cannabis and cannabinoid product research in South Africa. (South Africa/ Australia) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018595/
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. (Canada) (full – 2018) https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-fulltext-article-
DHPS Role of the cannabinoid signaling in the brain orexin- and ghrelin-induced visceral antinociception in conscious rats. (Japan) (full – 2018) https://www.sciencedirect.com/science/article/pii/S1347861318301002?via%3Dihub
Willingness to Participate in Longitudinal Research Among People with Chronic Pain Who Take Medical Cannabis: A Cross-Sectional Survey. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870058/
A Cross-Sectional Study of Cannabidiol Users. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043845/
. Marijuana Use in Adults Living with Sickle Cell Disease. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044416/
Evidence for THC versus CBD in cannabinoids. (Canada) (full – 2018) http://www.cfp.ca/content/64/7/519.long
Personal experience and attitudes of pain medicine specialists in Israel regarding the medical use of cannabis for chronic pain. (Israel/ UK) (full – 2018) https://www.dovepress.com/personal-experience-and-attitudes-of-pain-medicine-specialists-in-isra-peer-reviewed-fulltext-article-JPR
The Consumption of Cannabis by Fibromyalgia Patients in Israel. (Israel) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081591/
Identification of ABX-1431, a Selective Inhibitor of Monoacylglycerol Lipase and Clinical Candidate for Treatment of Neurological Disorders. (USA) (full – 2018) https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00951
Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor. (Spain) (full – 2018) https://molecularbrain.biomedcentral.com/articles/10.1186/s13041-018-0395-2
Comprehensive Examination of Therapies for Pain in Parkinson’s Disease: A Systematic Review and Meta-Analysis. (Canada/ Pakistan) (full – 2018) https://www.karger.com/Article/FullText/492221
Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain . (Italy) (full – 2018) https://www.dovepress.com/cannabinoids-and-spinal-cord-stimulation-for-the-treatment-of-failed-b-peer-reviewed-fulltext-article-JPR
Cannabis and the Health and Performance of the Elite Athlete. (Canada/ South Africa) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116792/
Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122691/
Marijuana Use by Adolescents and Young Adults with Inflammatory Bowel Disease (USA) (full – 2018) https://www.jpeds.com/article/S0022-3476(18)30388-3/fulltext
Emerging Evidence for Cannabis’ Role in Opioid Use Disorder. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135562/
Cannabinoid Delivery Systems for Pain and Inflammation Treatment. (Italy) (full – 2018) https://www.mdpi.com/1420-3049/23/10/2478/htm
Medical Cannabis in Patients with Chronic Pain: Effect on Pain Relief, Pain Disability, and Psychological aspects. A Prospective Non randomized Single Arm Clinical Trial. (Italy) (full – 2018) http://www.clinicaterapeutica.it/ojs/index.php/ClinicaTerapeutica/article/view/183/91
Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain. (Canada/ Italy/ USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319597/
Cannabis in palliative care: current challenges and practical recommendations. (Canada/ USA) (full – 2018) http://apm.amegroups.com/article/view/20097/21242
Erratum to cannabis in palliative care: current challenges and practical recommendations. (Canada/ USA) (erratum – 2018) http://apm.amegroups.com/article/view/23880/23545
Cannabis Use is Associated with Lower Odds of Prescription Opioid Analgesic Use Among HIV-Infected Individuals with Chronic Pain. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037547/
Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain. (USA) (full – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618307786
Cannabis for peripheral neuropathy: The good, the bad, and the unknown. (USA) (full – 2018) https://www.ccjm.org/content/85/12/943.long
Cannabinoids and Pain: New Insights From Old Molecules. (Serbia) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277878/
Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298870/
Care After Chemotherapy: Peripheral Neuropathy, Cannabis for Symptom Control, and Mindfulness. (USA) (full – 2018) https://ascopubs.org/doi/full/10.1200/EDBK_209437?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed Cannabis shenanigans: advocating for the restoration of an effective treatment of pain following spinal cord injury. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081457/
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. (USA/ Australia) (full – 2018) https://www.nature.com/articles/s41386-018-0011-2
Medicinal versus Recreational Cannabis Use among Returning Veterans. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037171/
Endocannabinoids, exercise, pain, and a path to health with aging. (USA) (full – 2018) https://www.researchgate.net/publication/328114934_Endocannabinoids_exercise_pain_and_a_path_to_health_with_aging
Association of Marijuana Use With Psychosocial and Quality of Life Outcomes Among Patients With Head and Neck Cancer. (Canada) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248184/
Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice. (USA/ Netherlands) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955845/
Risks and Benefits of Marijuana Use: A National Survey of U.S. Adults. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157909/
Characteristics and Patterns of Marijuana Use in Community-Dwelling Older Adults. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6476562/
Endogenous systems involved in exercise-induced analgesia. (Brazil) (full – 2018) http://www.jpp.krakow.pl/journal/archive/02_18/articles/01_article.html
Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study. (Israel) (full – 2018) http://anaesthesia-painmedicine.imedpub.com/effect-of-adding-medical-cannabis-treatment-mct-to-analgesic-treatment-in-patients-with-low-back-pain-related-to-fibromyalgia-an-o.php?aid=20234
An Outbreak of Synthetic Cannabinoid-Associated Coagulopathy in Illinois. (USA) (full – 2018) https://www.nejm.org/doi/full/10.1056/NEJMoa1807652
Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase synergize with the opioid analgesic morphine to suppress chemotherapy-induced neuropathic nociception without enhancing effects of morphine on gastrointestinal transit. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246979/
Supraspinal interaction between HIV-1-gp120 and cannabinoid analgesic effectiveness. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333524/
Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity. (UK) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177269/
Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy. (USA) (full– 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038031/
Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy- Induced Neuropathic Pain: Studies in Animal Models. (Kuwait) (full – 2018) https://www.hindawi.com/journals/prm/2018/5234943/
Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6699758/
An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. (Netherlands) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430597/
Association of Cannabinoid Administration With Experimental Pain in Healthy Adults: A Systematic Review and Meta-analysis. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248100/
The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447028/
Molecular mechanism of activation of the immunoregulatory amidase NAAA. (Canada/ USA) (full – 2018) https://www.pnas.org/content/115/43/E10032.long
Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057806/
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. (USA/ Australia) (full – 2018) https://www.nature.com/articles/s41386-018-0011-2
Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454895/
Long-Term Depression Induced by Optogenetically Driven Nociceptive Inputs to Trigeminal Nucleus Caudalis or Headache Triggers. (USA/ Republic of Korea) (full – 2018) http://www.jneurosci.org/content/38/34/7529.long
Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112616/
Accuracy of Patient Opioid Use Reporting at the Time of Medical Cannabis License Renewal. (USA) (link to full – 2018) https://www.hindawi.com/journals/prm/2018/5704128/
The role of cannabinoids in pain control: the good, the bad, and the ugly. (USA) (link to full with CAPCTHA code – 2018) https://www.minervamedica.it/en/journals/minerva-
anestesiologica/article.php?cod=R02Y2018N08A0955&html=1&htmlID=20H%2FJ%2FzJfllWbTQgG%2Bvg0sefo5GdruhwhCHuDx oDpD61KdeBk12dKITvfl98aZhJ6Y75DlKXV6PoFp9GqFlPuQ%3D%3D
Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice. (Czech Republic) (link to PDF – 2018) http://biomed.papers.upol.cz/artkey/bio-201801-0003_medical_cannabis_in_the_treatment_of_cancer_pain_and_spastic_conditions_and_options_of_drug_delivery_in_clinica.php
ANTINOCICEPTIVE TOLERANCE TO NSAIDS PARTIALLY MEDIATED VIA ENDOCANNABINOIDS IN ANTERIOR CINGULATE CORTEX OF RATS. (USA) (link to PDF – 2018) https://www.researchgate.net/publication/327603321_
Tolerance to hypothermic and antinoceptive effects of ∆9-tetrahydrocannabinol (THC) vapor inhalation in rats. (USA) (link to PDF – 2018) https://www.biorxiv.org/content/early/2018/05/30/172759.full.pdf+html
Practical considerations in medical cannabis administration and dosing. (Canada/ Czech Republic) (link to PDF – 2018) https://www.researchgate.net/publication/322257368_Practical_considerations_in_medical_cannabis_administration_and_dosing
Medical Cannabis for Older Patients. (Canada/ Germany) (link to PDF – 2018) https://www.researchgate.net/publication/329275718_Medical_Cannabis_for_Older_Patients

The association between perceived distress tolerance and cannabis use problems, cannabis withdrawal symptoms, and self-efficacy for quitting cannabis: The explanatory role of pain-related affective distress. (USA) (link to PDF – 2018) https://www.researchgate.net/publication/325321217_The_association_between_perceived_distress_tolerance_and_cannabis_use_problems_cannabis_withdrawal_symptoms_and_self-efficacy_for_quitting_cannabis_The_explanatory_role_of_pain-related_affective_distr
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders. (Israel) (link to PDF – 2018) https://www.researchgate.net/publication/325179753_Medical_Cannabis_for_Pediatric_Moderate_to_Severe_Complex_Motor_Disorders
The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial. (Mexico) (link to PDF – 2018) https://www.researchgate.net/publication/323831708_The_effect_of_nabilone_on_appetite_nutritional_status_and_quality_of_life_in_lung_cancer_patients_a_randomized_double-blind_clinical_trial
Effect of cannabidiolic acid and ∆9-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain. (Canada) (link to PDF – 2018) https://www.researchgate.net/publication/327705598_Effect_of_cannabidiolic_acid_and_9-tetrahydrocannabinol_on_carrageenan-induced_hyperalgesia_and_edema_in_a_rodent_model_of_inflammatory_pain
Inhibition of 2-arachydonoylgycerol degradation attenuates orofacial neuropathic pain in trigeminal nerve-injured mice. (Japan) (link to PDF – 2018) https://www.jstage.jst.go.jp/article/josnusd/advpub/0/advpub_17-0005/_article
Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract. (Italy) (download – 2018) https://scienzemedicheveterinarie.unibo.it/it/risorse/files/dottorati-xxxii-ciclo/galiazzo-giorgia-giugno-2018-32-ciclo
Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators. (USA) (link to download – 2018) http://jpet.aspetjournals.org/content/jpet/early/2018/10/10/jpet.118.252296.full.pdf 
Attitudes of Irish patients with chronic pain towards medicinal cannabis. (Ireland) (link to download – 2018) http://map.amegroups.com/article/viewFile/4132/5098
Restored Self: A Phenomenological Study of Pain Relief by Cannabis. (Israel) (link to download – 2018) https://www.cedfoundation.com/wp-content/uploads/2019/11/Restored-Self-A-Phenomenological-Study-of-Pain-Relief-by-Cannabis.pdf
Medical Marijuana for Chronic Pain. (USA) (click first result for download – 2018) https://scholar.google.com/scholar?cluster=13917588283352033714&hl=en&as_sdt=0,5&as_vis=1
The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews. (Australia) (click “usyd” for download– 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+Use+of+Cannabis+and+Cannabinoids+in+Treating+Symptoms+of+Multiple+Sclerosis%3A+a+Systematic+Review+of+Reviews.+&btnG
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. (Israel) (click “researchgate” for download – 2018) https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5
When orexins meet cannabinoids: Bidirectional functional interactions. (Spain) (click “ufves” for download – 2018) https://scholar.google.com/scholar?q=%22When+orexins+meet+cannabinoids:+Bidirectional+functional+interactions%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
Pharmacological modulation of colorectal distension evoked potentials in conscious rats. (Denmark/ Sweden) (click “aaudk” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Pharmacological+modulation+of+colorectal+distension+evoked+potentials+in+conscious+rats&btnG
Cannabis for Chronic Pain: Challenges and Considerations. (USA) (click “cedfoundation” for download – 2018) https://scholar.google.com/scholar?q=Cannabis+for+Chronic+Pain:+Challenges+and+Considerations.&hl=en&as_sdt=0&as_vis=1&oi=scholart
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science. (USA) (click “tonemellow” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Medicinal+Properties+of+Cannabinoids%2C+Terpenes%2C+and+Flavonoids+in+Cannabis%2C+and+Benefits+in+Migraine%2C+Headache%2C+and+Pain%3A+An+Update+on+Current+Evidence+and+ Cannabis+Science.&btnG
The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. (USA) (click “mmpmacom” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+therapeutic+effects+of+Cannabis+and+cannabinoids%3A+An+update+from+the+National+%09Academies+of+Sciences%2C+Engineering+and+Medicine+report.&btnG
Effects of Legal Access to Cannabis on Scheduled II–V Drug Prescriptions. (USA) (click “komornlaw” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=ffects+of+Legal+Access+to+Cannabis+on+Scheduled+II%E2%80%93V+Drug+Prescriptions&btnG
Cannabinoids: just like any other medication? (UK) (article – 2018) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31611-8/fulltext
Medical Marijuana in Cancer Treatment: No Standards of Care, and So Far, No Coverage. (USA) (article – 2018) https://www.ajmc.com/journals/evidence-based-oncology/2018/october-2018/medical-marijuana-in-cancer-treatment-no-standards-of-
care-and-so-far-no-coverage
Perception Versus Evidence: Cannabinoids as a Postoperative Analgesic Panacea? (Australia) (letter – 2018) https://rapm.bmj.com/content/43/3/331.1
Cannabis and the Opioid Crisis. (USA) (interview – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931647/
Cannabinoid therapy in practice. (Germany) (abst in German & English- 2018) https://link.springer.com/article/10.1007%2Fs00120-018-0636-0
Beneficial Effect of Medical Cannabis in the Treatment of a Pharmacoresistant Nausea Associated with a Somatoform Disorder in a Patient with Post-Polio Syndrome. (Germany) (abst in English & German – 2018) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-123897
Cannabinoids in pain medicine. (Germany) (abst in German & English – 2018) https://link.springer.com/article/10.1007%2Fs00482-018-0299-1
CB1 cannabinoid receptor agonist mouse VD-hemopressin(α) produced supraspinal analgesic activity in the preclinical models of pain. (China) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0006899317305474

Contribution of spinal 5-HT5A receptors to the antinociceptive effects of systemically administered cannabinoid agonist WIN 55,212-2 and morphine. (Turkey) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29406831
Functional effects of synthetic cannabinoids versus Δ9 -THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor/exploratory parameters and depression. (Israel) (abst – 2018) https://www.semanticscholar.org/paper/Functional-effects-of-synthetic-cannabinoids-versus-Schreiber-Bader/bdcc732eca01fb98bf65981d65180ad3c9839dd5
Mechanisms and treatment of painful neuromas. (China) (abst – 2018) https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0077/revneuro-2017-0077.xml
Antinociceptive effects of the endogenous cannabinoid peptide agonist VD- hemopressin(β) in mice. (China) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0361923017307621
Should Cannabinoids Be Added to Multimodal Pain Regimens After Total Hip and Knee Arthroplasty? (USA) (abst – 2018) https://www.arthroplastyjournal.org/article/S0883-5403(18)30670-3/fulltext
Plasma N-acylethanolamine and endocannabinoid levels in burning mouth syndrome: potential role in disease pathogenesis. (Ireland) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29436743
Pain interference and alcohol, nicotine, and cannabis use disorde
r in a national sample of substance users. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618301169

Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids. (Canada) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S1471489218300043?via%3Dihub
Effects of cannabinoid type 2 receptor agonist AM1241 on morphine-induced antinociception, acute and chronic tolerance, and dependence in mice. (China) (abst – 2018) https://www.jpain.org/article/S1526-5900(18)30159-7/fulltext
Cannabinoid receptor type 1 in the brain regulates the affective component of visceral pain in mice. (Germany) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306452218303919
The prefrontal cortical endocannabinoid system modulates fear-pain interactions in a subregion-specific manner. (Ireland) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29847859
Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain. (China) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29863609
The relationship of endocannabinoidome lipid mediators with pain and psychological stress in women with fibromyalgia – a case control study. (Sweden) (abst – 2018) https://www.jpain.org/article/S1526-5900(18)30197-4/fulltext
Cannabinoids for Treatment of MS Symptoms: State of the Evidence. (USA) (abst – 2018) https://link.springer.com/article/10.1007%2Fs11910-018-0859-x
FAAH inhibition attenuates TLR3-mediated hyperthermia, nociceptive- and anxiety-like behaviour in female rats. (Ireland) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S016643281830250X?via%3Dihub
https://www.semanticscholar.org/paper/FAAH-inhibition-attenuates-TLR3-mediated-and-in-Flannery-Kerr/c93c7dd2bfa2efe1c875df4e7e3b984d08e52399
Therapeutic applications of cannabinoids. (India/ Vietnam) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0009279718307373
Chronic pain and cannabinoids. Great expectations or a christmas carol. (Spain) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303010
https://www.semanticscholar.org/paper/Chronic-pain-and-cannabinoids.-Great-expectations-a-Pascual-S%C3%A1nchez-Robles/88122625bafb12d19202173bd5c67e202f1d8336
Orthopaedic surgery patients who use recreational marijuana have less pre-operative pain (USA) (abst–2018) https://www.semanticscholar.org/paper/Orthopaedic-surgery-patients-who-use-recreational-Medina-Nadarajah/89ca7cbe304eac973956b0b21b16d886b6a3bc60
The association between physical pain and cannabis use in daily life: An experience sampling method. (Israel) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618304678
Glial Endocannabinoid System in Pain Modulation. (China) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30084280
Ximenia americana heteropolysaccharides ameliorate inflammation and visceral hypernociception in murine caerulein-induced acute pancreatitis: Involvement of CB2 receptors. (Brazil/ UK) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S075333221831970X
The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome. (USA/ Poland/ Germany) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0014299918304734?via%3Dihub
Bortezomib And Endocannabinoid/Endovanilloid System: A Synergism In Osteosarcoma. (Italy) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S1043661818310387
Medical Cannabis Use by Hodgkin Lymphoma Patients: Experience of a Single Center. (Israel) (abst – 2018) https://www.karger.com/Article/Abstract/493567
https://www.semanticscholar.org/paper/Medical-Cannabis-Use-by-Hodgkin-Lymphoma-Patients%3A-Sarid-Zada/bf3e12345cb8ff18d38a306e31a979901907e4f3
Dermatology-Related Uses of Medical Cannabis Promoted by Dispensaries in Canada, Europe, and the United States. (Canada) (abst – 2018) http://journals.sagepub.com/doi/abs/10.1177/1203475418808761?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=cmsa
The level of evidence of medical marijuana use for treating disabilities: a scoping review. (USA) (abst – 2018) https://www.tandfonline.com/doi/abs/10.1080/09638288.2018.1523952
Impact of recreational and medicinal marijuana on surgical patients: A review. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0002961018311231
Benefits and adverse effects of cannabis use among adults with persistent pain. (USA) (abst – 2018) https://www.nursingoutlook.org/article/S0029-6554(18)30563-3/fulltext
2019 Cannabis and Cannabinoids (PDQ®) Patient Version. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK65875/
2019 Cannabis and Cannabinoids (PDQ®)Health Professional Version. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK65755/
Self-management strategies amongst Australian women with endometriosis: a national online survey. (Australia) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332532/
Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55. (Mexico/ USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331465/
US Veterinarians’ Knowledge, Experience, and Perception Regarding the Use of Cannabidiol for Canine Medical Conditions. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338022/
Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Cannabinoids for Chronic Pain: Protocol for a Systematic Review. (Canada/ USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369421/
Characterizing chronic pain in late adolescence and early adulthood: prescription opioids, marijuana use, obesity, and predictors for greater pain interference. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344139/
Qualifying Conditions of Medical Cannabis License Holders in the United States. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398594/
An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine. (USA) (full – 2019) https://link.springer.com/article/10.1007%2Fs40122-019-0114-4
Spontaneous, anecdotal, retrospective, open-label study on the efficacy, safety and tolerability of cannabis galenical preparation (Bedrocan). (Italy) (full – 2019) https://onlinelibrary.wiley.com/doi/full/10.1111/ijpp.12514
Cannabis money opens new opportunities, and ethical dilemmas, for medical research. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379174/
Medicinal use of cannabis based products and cannabinoids. (UK) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447998/
Patterns of Marijuana Use and Health Impact: A Survey Among Older Coloradans. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487769/
Diverse TRPV1 responses to cannabinoids. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557596/
The New Runner’s High? Examining Relationships Between Cannabis Use and Exercise Behavior in States With Legalized Cannabis. (USA) (full – 2019) https://www.frontiersin.org/articles/10.3389/fpubh.2019.00099/full

Management of Chronic Pain in Adults Living With Sickle Cell Disease in the Era of the Opioid Epidemic: A Qualitative Study. (USA) (full – 2019) https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2734070
Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry. (Germany) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535492/
Safety and Efficacy of Medical Cannabis in Fibromyalgia. (Israel) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616435/
Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study. (Israel) (full – 2019) https://www.cambridge.org/core/journals/palliative-and-supportive-care/article/cannabis-treatment-in-hospitalized-patients-using-the-
syqe-inhaler-results-of-a-pilot-openlabel-study/0C1940413E704A7EADCB949F5F49603A/core-reader
Medical Cannabis Certification in a Large Pediatric Oncology Center. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617193/
Cannabis use in active athletes: Behaviors related to subjective effects. (USA/ Brazil) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598761/
The use of cannabis in supportive care and treatment of brain tumor. (Austria) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655483/
Role for Endocannabinoids in Spinal Manipulative Therapy Analgesia? (USA) (full – 2019) https://www.hindawi.com/journals/ecam/2019/2878352/
Cannabinoid Receptor 2 Agonist JWH-015 Inhibits Interleukin-1β-Induced Inflammation in Rheumatoid Arthritis Synovial Fibroblasts and in Adjuvant Induced Arthritis Rat via Glucocorticoid Receptor. (USA) (full – 2019) https://www.frontiersin.org/articles/10.3389/fimmu.2019.01027/full
The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma. (Italy) (full – 2019) https://www.mdpi.com/1422-0067/20/8/1919/htm
Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency- mediated chronic pain. (Italy/ Canada) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0889159118312479?via%3Dihub
Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity. (Qatar/ UK/ Canada/ USA) (full – 2019) https://bjanaesthesia.org/article/S0007-0912(19)30138-2/fulltext
Myrcene and terpene regulation of TRPV1. (USA) (full – 2019) https://www.tandfonline.com/doi/full/10.1080/19336950.2019.1654347
The Endocannabinoid System of Animals. (USA) (full – 2019) https://www.mdpi.com/2076-2615/9/9/686/htm
Medical Cannabis for the Treatment of Chronic Pain: A Review of Clinical Effectiveness and Guidelines [Internet]. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK546424/
Non-prescription cannabis use for symptom management amongst women with gynecologic malignancies. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804884/
Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726263/
Should more patients be offered treatment with cannabinoids? (Norway) (full – 2019) https://tidsskriftet.no/en/2019/09/kronikk/should-more-patients-be-offered-treatment-cannabinoids
Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review. (Italy) (full – 2019) https://systematicreviewsjournal.biomedcentral.com/articles/10.1
186/s13643-018-0934-z Analgesic effects of FAAH inhibitor in the insular cortex of nerve-injured rats. (Republic of Korea) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247483/
Median nerve stimulation induces analgesia via orexin-initiated endocannabinoid disinhibition in the periaqueductal gray. (Taiwan/ Malaysia/ Germany/ USA) (full – 2019) https://www.pnas.org/content/115/45/E10720.long
Patients’ and clinicians’ perspectives of co-use of cannabis and opioids for chronic non- cancer pain management in primary care. (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0955395918302287
Cannabis for musculoskeletal pain and arthritis: Evidence is needed. (France) (full – 2019) https://www.sciencedirect.com/science/article/pii/S1297319X18300472
Medical Cannabis for Older Patients-Treatment Protocol and Initial Results. (Israel) (full – 2019) https://www.mdpi.com/2077-0383/8/11/1819/htm
Is substance use disorder more prevalent in patients with hidradenitis suppurativa? (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S2352647519301066
Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease. (Italy) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667638/
Management of chronic pain with Jalaprakshalana (water-wash) Shodhita (processed) Bhanga (Cannabis sativa L.) in cancer patients with deprived quality of life: An open- label single arm clinical trial. (Jalaprakshalana = water curing until water is clear.- GSC) (India) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891996/
The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study. (Israel/ USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785913/
Opportunities for cannabis in supportive care in cancer. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676264/
Metabolic syndrome and osteoarthritis pain: common molecular mechanisms and potential therapeutic implications. (UK) (full – 2019) https://www.oarsijournal.com/article/S1063-4584(19)31154-9/fulltext
Combined tetrahydrocannabinol and cannabidiol to treat pain in epidermolysis bullosa: a report of three cases. (Netherlands) (full – 2019) https://onlinelibrary.wiley.com/doi/full/10.1111/bjd.17341
The impact of cannabis access laws on opioid prescribing. (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0167629618309020?via%3Dihub
Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia. (Italy) (full – 2019) https://www.frontiersin.org/articles/10.3389/fvets.2019.00313/full
Corrigendum: Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia. (Italy) (full – 2019) https://www.frontiersin.org/articles/10.3389/fvets.2019.00377/full
Medical Cannabis Use in Palliative Care: Review of Clinical Effectiveness and Guidelines – An Update [Internet]. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK551867/
Is substance use disorder more prevalent in patients with hidradenitis suppurativa? (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S2352647519301066?via%3Dihub
Cannabis-based medicinal products. (UK) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK552187/
Medical Cannabis in Treatment of Resistant Familial Mediterranean Fever. (Israel) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753661/
Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. (USA) (full – 2019) https://link.springer.com/article/10.1007%2Fs
11606-018-4782-2 Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878658/
Cannabidiol (CBD) for Treatment of Neurofibromatosis-related Pain and Concomitant Mood Disorder: A Case Report. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944157/
Comparative studies of endocannabinoid modulation of pain. (USA) (full – 2019) https://royalsocietypublishing.org/doi/abs/10.1098/rstb.2019.0279?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-
2003&rfr_id=ori%3Arid%3Acrossref.org Cannabis sativa as a Potential Treatment for Systemic Sclerosis. (Israel/ Portugal) (link to PDF – 2019) https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2019&month=03&page=217
Cannabinoid receptor 2-selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord. (China) (link to PDF – 2019) https://www.spandidos-publications.com/10.3892/mmr.2019.10772
Antinociceptive and Abuse Potential Effects of Cannabinoid/Opioid Combinations in a Chronic Pain Model in Rats. (Jordan/ Saudi Arabia) (link to PDF – 2019) https://www.mdpi.com/2076-3425/9/11/328
The Effect of Medical Marijuana Laws on the Health and Labor Supply of Older Adults: Evidence from the Health and Retirement Study. (USA) (link to PDF – 2019) https://www.nber.org/papers/w22688
[EXPRESS] Altered relationship between anandamide and glutamate in circulation after 30 minutes of arm cycling: A comparison of chronic pain subject with healthy controls. (Sweden) (link to PDF – 2019) https://journals.sagepub.com/doi/abs/10.1177/1744806919898360
The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review. (USA) (link to PDF – 2019) https://www.researchgate.net/publication/333265797_The_Potential_Benefits_of_Palmitoylethanolamide_in_Palliation_A_Qualitative_Systematic_Review
Cannabinoids in the treatment of rheumatic diseases: Pros and cons. (Italy/ Israel/ Germany/ Canada/) (link to PDF – 2019) https://www.researchgate.net/publication/336710270_Cannabinoids_in_the_treatment_of_rheumatic_diseases_Pros_and_cons
Patient Counseling Guidelines for the Use of Cannabis for the Treatment of Chemotherapy-Induced Nausea/Vomiting and Chronic Pain. (USA/ Finland) (link to PDF – 2019) https://www.researchgate.net/publication/332995076_Patient_Counseling_Guidelines_for_the_Use_of_Cannabis_for_the_Treatment_of_Chemotherapy-Induced_NauseaVomiting_and_Chronic_Pain
Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain. (Australia) (link to PDF – 2019) https://www.researchgate.net/publication/3303345
14_Understanding_the_evidence_for_medical_cannabis_and_cannabis- based_medicines_for_the_treatment_of_chronic_non-cancer_pain
Cannabis for pain in orthopedics: a systematic review focusing on study methodology. (Canada/ Netherlands / Spain) (link to PDF, full in English & abst in French – 2019) http://canjsurg.ca/62-6-001018/
Opioid and endocannabinoid system in orofacial pain. (Poland) (link to download – 2019) Opioid and Endocannabinoid System in Orofacial Pain Cannabinoids: a new approach for pain control? (Belgium) (click “bordetbe” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&as_vis=1&q=%22Cannabinoids%3A+a+new+approach+for+pain+control%3F%22&btnG
Joints for joints: cannabinoids in the treatment of rheumatoid arthritis. (Germany) (click “shayahealth” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Joints+for+joints%3A+cannabinoids+in+the+treatment+of+rheumatoid+arthritis.%22&btnG
Medical cannabis and cannabinoids in rheumatology: where are we now? (Italy/ Germany/Israel) (click “researchgate” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Medical+cannabis+and+cannabinoids+in+rheumatology%3A+where+are+we+now%3F++%22&btnG
Driving under the influence of cannabis among medical cannabis patients with chronic pain. (USA) (click “publicbroadcastingnet” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Driving+under+the+influence+of+cannabis+among+medical+cannabis+patients+with+chronic+pain%22&btnG
Endocannabinoid and Prostanoid Crosstalk in Pain. (Belgium) (click “uclouvainbe” for download – 2019) https://scholar.google.com/scholar?q=%22Endocannabinoid+and+Prostanoid+Crosstalk+in+Pain.+%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions. (USA) (click “biorxivorg” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%CE%949-tetrahydrocannabinol+attenuates+oxycodone+self-administration+under+extended+access+conditions&btnG
Cannabis and Pain. (Czech Republic) (article – 2019) https://academic.oup.com/painmedicine/advance-article/doi/10.1093/pm/pnz227/5570564
Medical Marijuana Redux. (USA) (article – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368053/
Cancer, Cannabis, and the Search for Relief. (USA) (article – 2019) https://jnccn.org/view/journals/jnccn/17/9/article-p1142.xml
Should Oncologists Recommend Cannabis? (USA) (article – 2019) https://link.springer.com/article/10.1007%2Fs11864-019-0659-9
Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey. st (Germany/ USA) (1 page – 2019) https://www.deepdyve.com/lp/springer-journal/cannabis
-use-in-myotonic-dystrophy-patients-in-germany-and-usa-a-pilot- maEwTVPdeX?key=bioportfolio Therapeutic applications by cannabinoid action/ Aplicaciones terapéuticas por acción de los cannabinoides. (Mexico) (abst in English, full in Spanish – 2019) http://gacetamedicademexico.com/frame_esp.php?id=310
Efficacy and safety of medicinal cannabis: results of the CaPRis study. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02965-3
Cannabis medicines in pain management : Interim analysis of the survey accompanying the prescription of cannabis-based medicines in Germany with regard to pain as primarily treated symptom. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00482-019-00399-z
Interim analysis of the survey accompanying insurance-covered prescriptions of cannabis-based medicines in Germany. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02968-0
Progress in cannabis research from a pharmaceutical chemist’s point of view. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02964-4
Cannabis and cannabinoids in palliative care. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02967-1
The use of cannabis-based drugs in pain and palliative medicine : Joint online questionnaire conducted by the Professional Association of Physicians and Psychotherapists in Pain and Palliative Medicine in Germany (BVSD), the German Pain Society, and the German Society for Pain Medicine (DGS). (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00482-019-00406-3
Dronabinol in geriatric pain and palliative care patients. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00482-019-00408-1
Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. (Israel) (abst – 2019) https://www.tandfonline.com/doi/abs/10.1080/13543784.2019.1561859?journalCode=ieid20
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S2211034818305157
Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain. (USA) (abst – 2019) https://www.jpain.org/article/S1526-5900(18)30735-1/fulltext
Survey on current treatments for pain after spinal cord damage. (Australia/ USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30729038
Pain Relief as a Motivation for Cannabis Use Among Young Adult Users With and Without Chronic Pain. (USA) (abst – 2019) https://www.jpain.org/article/S1526-5900(18)30488-7/fulltext
Prevalence and correlates of medical cannabis patients’ use of cannabis for recreational purposes. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306460318311419
Cannabis Oil Use by Adolescents and Young Adults With Inflammatory Bowel Disease. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30801394
Using Cannabis to Treat Cancer-Related Pain. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0749208119300609
Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31120286
Illegal cannabis use is common among Danes with multiple sclerosis. (Denmark) (abst – 2019) https://www.msard-journal.com/article/S2211
-0348(19)30212-3/fulltext Medical Cannabis: Effects on Opioid and Benzodiazepine Requirements for Pain Control. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31129977
Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain. (USA) (abst – 2019) https://www.jpain.org/article/S1526-5900(19)30067-7/fulltext
Predicting Physicians’ Intentions to Recommend Medical Cannabis. (Israel) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31145978
Use of Cannabis to Relieve Pain and Promote Sleep by Customers at an Adult Use Dispensary. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31264536
Cannabis-based medicines for chronic pain management: current and future prospects. (Israel/ UK) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31356363
Associations of PTSD, chronic pain, and their comorbidity on cannabis use disorder: Results from an American nationally representative study. (Canada) (abst – 2019) https://onlinelibrary.wiley.com/doi/abs/10.1002/da.22947
Cannabis Use Motivations among Adults Prescribed Opioids for Pain versus Opioid Addiction. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31375419
OPRM1 rs1799971, COMT rs4680, and FAAH rs324420 genes interact with placebo procedures to induce hypoalgesia. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31335650
Endocannabinoid and N-acylethanolamide levels in rat brain and spinal cord following systemic dipyrone and paracetamol administration. (Turkey) (abst – 2019) https://www.nrcresearchpress.com/doi/abs/10.1139/cjpp-2019-0015
Diet, endocannabinoids, and health. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S027153171930572X?via%3Dihub
Disagreement and Uncertainty Among Experts About how to Respond to Marijuana Use in Patients on Long-term Opioids for Chronic Pain: Results of a Delphi Study (USA) (abst–2019) https://academic.oup.com/painmedicine/advance-article-abstract/doi/10.1093/pm/pnz153/5545189?redirectedFrom=fulltext
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31207606
Cannabinoids: Current and Future Options to Treat Chronic and Chemotherapy-Induced Neuropathic Pain. (USA) (abst – 2019) https://link.springer.com/article/10.1007%2Fs40265-019-01132-x
https://www.semanticscholar.org/paper/Cannabinoids%3A-Current-and-Future-Options-to-Treat-Blanton-Brelsfoard/fb04164e343f13f89a221bd736f7504f7c9b5d6c
The endocannabinoid system in migraine: from bench to pharmacy and back. (Italy/ USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30883435
The effectiveness of self-directed medical cannabis treatment for pain. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0965229919308040
Reduced urinary opioid levels from pain management patients associated with marijuana use. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31496363
Medical cannabis for chronic pain: can it make a difference in pain management? (Malaysia) (abst – 2019) https://link.springer.com/article/10.1007%2Fs00540-019-02680-y
Perception of Benefits and Harms of Medical Cannabis among Seriously Ill Patients in an Outpatient Palliative Care Practice. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31539298
Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats. (Portugal/ UK) (abst – 2019) https://link.springer.com/article/10.1007%2Fs00210-019-01729-9
https://www.semanticscholar.org/paper/Fatty-acid-amide-hydrolase-inhibition-normalises-in-Charrua-Matos/0875f1b3e95b5e3e0fd8b8da2de5ee8d3dc63e3a
Endocannabinoid modulation of inflammatory hyperalgesia in the IFN-α mouse model of depression (Ireland) (abst–2019) https://www.sciencedirect.com/science/article/pii/S0889159119306063?via%3Dihub
Low intensity blood flow restriction exercise: Rationale for a hypoalgesia effect (UK) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0306987719307364
Updated mechanisms underlying sickle cell disease-associated pain. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0304394019305749
Endogenous cannabinoid modulation of restraint stress-induced analgesia in thermal nociception. (Australia) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31571215
Cannabinoids, Pain, and Opioid Use Reduction: The Importance of Distilling and Disseminating Existing Data. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31579833
Role of Cannabinoids and Terpenes in Cannabis-Mediated Analgesia in Rats (USA) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31579834
Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education. (Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31579835
Pharmacokinetics, pharmacodynamics and safety studies on URB937, a peripherally restricted fatty acid amide hydrolase inhibitor, in rats. (USA/ Italy) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31579946
Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain. (Poland) (abst – 2019) https://www.semanticscholar.org/paper/Role-of-endocannabinoid-system-in-dopamine-within-Mlost-W%C4%85sik/8ead21c33539fa530f887472c42bec2c88969902
The effect of cannabis laws on opioid use. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0955395919302567
The potential role of cannabinoids in dermatology. (Australia/ USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31599175
The Impact of Medical Marijuana Laws and Dispensaries on Self-Reported Health. (Canada) (abst – 2019) https://www.degruyter.com/view/j/fhep.ahead-of-print/fhep-2019-0002/fhep-2019-0002.xml?lang=en
Cannabinoid effects on responses to quantitative sensory testing among individuals with and without clinical pain: a systematic review. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31613869
The challenge of pain in the pharmacological management of Parkinson’s disease. (Germany) (abst – 2019) https://www.tandfonline.com/doi/abs/10.1080/14656566.2019.1639672?journalCode=ieop20
Cannabidiol As A Novel Therapeutic Strategy For Oral Inflammatory Diseases: A Review Of Current Knowledge And Future Perspectives. (Czech Republic) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31634872
Using cannabis for pain management after spinal cord injury: a qualitative study. (New Zealand/ Australia) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31632740
Utilization of medicinal cannabis for pain by individuals with spinal cord injury. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31632724
Medical Cannabis for the Primary Care Physician. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31646929
A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patients. (Germany) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31655890
Pain Relief as a Motivation for Cannabis Use Among Young Adult Users With and Without Chronic Pain. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1526590018304887
Predicting Physicians’ Intentions to Recommend Medical Cannabis. (Israel) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0885392419302921
The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis. (Thailand/ USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S154431911930353X
Patient Outcomes Following Initiation of Medical Cannabis in Women with Chronic Pelvic Pain. (Canada) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S1553465019311628
An Integrated Review of Cannabis and Cannabinoids in Adult Oncologic Pain Management. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1524904218302091
Cannabis Use Motivations among Adults Prescribed Opioids for Pain versus Opioid Addiction. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1524904219300967
Exploring cancer survivors’ attitudes, perceptions, and concerns about using medical cannabis for symptom and side effect management: A qualitative focus group study. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0965229919309252
Perceived Efficacy of Medical Cannabis in the Treatment of Co-Occurring Health- Related Quality of Life Symptoms. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31693457
Self-Reported Efficacy of Cannabis for Endometriosis Pain. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S1553465019310921
Antinociceptive effects of treadmill exercise in a rat model of Parkinson’s disease: the role of cannabinoid and opioid receptors. (Brazil) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S000689931930575X?via%3Dihub
Evaluation of the effects of CBD hemp extract on opioid use and quality of life indicators in chronic pain patients: a prospective cohort study. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31711352
Short- and Long-Term Effects of Cannabis on Headache and Migraine. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31715263
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson’s disease. (Brazil) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0028390819303703?via%3Dihub
Cannabis Use, a Self-Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey. (Australia) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31722852
Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. (USA/ Italy) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1474442219300328
Can CBD Reduce the Use of Pain Medication? Lessons from a Survey in a Pain Clinic Environment. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1526590019306522
Cannabidiol, cannabinol and their combinations act as peripheral analgesics in a rat model of myofascial pain. (Canada) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0003996919302249
Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice. (Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31766439
Pain Management in Multiple Sclerosis: a Review of Available Treatment Options. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31773455
Exploring cancer survivors’ attitudes, perceptions, and concerns about using medical cannabis for symptom and side effect management: A qualitative focus group study. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0965229919309252?via%3Dihub
Investigation of the Involvement of the Endocannabinoid System in TENS-induced Antinociception. (Brazil) (abst – 2019) https://www.jpain.org/article/S1526-5900(19)30868-5/fulltext
The role of the endocannabinoid system in aetiopathogenesis of endometriosis: A potential therapeutic target. (Australia/ Switzerland) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31785471
The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31793418
Medicinal Cannabis in Orthopaedic Practice. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31800438
Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain. (USA) (abst – 2019) https://www.nature.com/articles/s41386-019-0585-3
Cannabis Use in Children With Pantothenate Kinase-Associated Neurodegeneration (USA) (abst–2019) https://journals.sagepub.com/doi/abs/10.1177/0883073819890516?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=jcna
Cannabis-based medicines and the perioperative physician. (Canada/ UK) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31827774
Delta-9-tetrahydrocannabinol reduces the performance in sensory delayed discrimination tasks. A pharmacological-fMRI study in healthy volunteers (Germany) (abst–2019) https://www.ncbi.nlm.nih.gov/pubmed/31828232
Neurotransmitter systems involved in placebo and nocebo effects in healthy participants and patients with chronic pain: a systematic review. (Denmark/ Sweden) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31453980
Characteristics of Marijuana Use Among Orthopedic Patients. (USA/ Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31841610
Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis- associated pain. (Spain) (full – 2020) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977967/
Challenges and Opportunities in Preclinical Research of Synthetic Cannabinoids for Pain Therapy. (Romania) (full – 2020) https://www.mdpi.com/1010-660X/56/1/24/htm
Impact of Cannabinoids on Symptoms of Refractory Gastroparesis: A Single-center Experience. (USA) (full – 2020) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970440/
Combatting joint pain and inflammation by dual inhibition of monoacylglycerol lipase and cyclooxygenase-2 in a rat model of osteoarthritis. (Canada) (full – 2020) https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-020-2096-3
Cannabidiol prescription in clinical practice: an audit on the first 400 patients in New Zealand. (New Zealand) (link to PDF- 2020) https://www.researchgate.net/publication/339046590_Cannabidiol_prescription_in_clinical_practice_an_audit_on_the_first_400_patients_in_New_Zealand
Cannabis and Pain Treatment-A Review of the Clinical Utility and a Practical Approach in Light of Uncertainty. (Israel/ Canada) (download – 2020) https://www.rmmj.org.il/userimages/1002/2/PublishFiles/1035Article.pdf
Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases. (Israel) (link to download – 2020) https://www.rmmj.org.il/userimages/1006/1/PublishFiles/1025Article.pdf
Therapeutic Uses of Cannabis on Sleep Disorders and Related Conditions. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31895189
Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus. (Brazil/ Pakistan) (abst – 2020) https://link.springer.com/article/10.1007%2Fs00213-019-05435-5
Oncologists’ perspectives on medical marijuana use by older adults. (USA) (abst – 2020) https://www.geriatriconcology.net/article/S1879-4068(19)30413-8/fulltext
The relationships between chronic pain and changes in health with cannabis consumption patterns. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31931439
Cannabinoids CB2 Receptors, One New Promising Drug Target for Chronic and Degenerative Pain Conditions in Equine Veterinary Patients. (Mexico) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31952645
Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study. (Israel) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31959585
Analgesic prescribing habits and patterns of Canadian chief urology residents: A national survey. (Canada) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31977305
An evaluation of the anti‐hyperalgesic effects of cannabidiolic acid‐methyl ester (CBDA‐ ME) in a preclinical model of peripheral neuropathic pain. (Canada/ Israel) (abst – 2020) https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.14997
Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population. (USA) (abst – 2020) https://journals.sagepub.com/doi/abs/10.1177/1049909119900378?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=ajhb
Cannabinoids in the descending pain modulatory circuit: Role in inflammation. (USA) (abst – 2020) https://www.sciencedirect.com/science/article/abs/pii/S0163725820300231
Survey on current treatments for pain after spinal cord damage. (USA/ Australia) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/32019909
Marijuana, lower urinary tract symptoms, and pain in the urologic patient. (USA) (abst – 2020) https://www.goldjournal.net/article/S0090-4295(20)30113-8/fulltext
HYPNOTIZABILITY-RELATED FAAH C385A POLYMORPHISM: POSSIBLE ENDOCANNABINOID CONTRIBUTION TO SUGGESTION-INDUCED ANALGESIA. (Italy) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31914367
Attenuation of fear-conditioned analgesia in rats by monoacylglycerol lipase inhibition in the anterior cingulate cortex: Potential role for CB2 receptors. (Ireland) (abst – 2020) https://bpspubs.onlinelibrary.wiley.com/doi/abs/10.1111/bph.14976


PALLIATIVE CARE
Assessment of Israeli Physicians’ Knowledge, Experience and Attitudes towards Medical Cannabis: A Pilot Study. (Israel) (link to PDF – 2015) http://www.ima.org.il/IMAJ/ViewArticle.aspx?year=2015&month=07&page=437
Legal issues for German-speaking cannabis growers. Results from an online survey. (Germany) (link to PDF – 2015) https://www.researchgate.net/publication/286023920_Legal_issues_for_German-
speaking_cannabis_growers_results_from_an_online_survey Use of cannabinoids in cancer care: palliative care. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791145/
Opioids Out, Cannabis In Negotiating the Unknowns in Patient Care for Chronic Pain. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332546/
Effective treatment of spasticity using dronabinol in pediatric palliative care. (Germany) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S1090379816301271
Islamic theology and the principles of palliative care. (Saudi Arabia) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27109307
P048 Beliefs and Experiences of Patients Receiving Specialist Palliative Care, and Their Physicians, on the Use of Cannabis and Synthetic Cannabinoids. (Canada) (abst – 2016) https://www.jpsmjournal.com/article/S0885-3924(16)30529-2/abstract
Cannabinoids in Pain Management and Palliative Medicine. (Germany/ Canada) (full in English, link to full in German – 2017) https://www.aerzteblatt.de/int/archive/article?id=193441
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications. (Israel) (link to PDF – 2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
Knowledge, Skills, and Attitudes Regarding the Use of Medical Cannabis in the Hospice Population: An Educational Intervention. (USA) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/29121790
Preserving the independence of people living with multiple sclerosis towards the end of life. (UK) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/29087751
The current state and future perspectives of cannabinoids in cancer biology. (Poland) (full – 2018) http://onlinelibrary.wiley.com/doi/10.1002/cam4.1312/full
Medicinal Cannabinoids in Palliative Care. (Australia) (full – 2018) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.13671
Cannabis in palliative care: current challenges and practical recommendations. (Canada/ USA) (full – 2018) http://apm.amegroups.com/article/view/20097/21242
Erratum to cannabis in palliative care: current challenges and practical recommendations. (Canada/ USA) (erratum – 2018) http://apm.amegroups.com/article/view/23880/23545
Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis. (Portugal) (link to PDF – 2018) https://www.researchgate.net/publication/323158392_Cannabinoid-
induced_cell_death_in_endometrial_cancer_cells_involvement_of_TRPV1_receptors_in_apoptosis Medical Cannabis for Older Patients. (Canada/ Germany) (link to PDF – 2018) https://www.researchgate.net/publication/329275718_Medical_Cannabis_for_Older_Patients
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. (Israel) (click “researchgate” for download – 2018) https://scholar.google.com/scholar?cluster=325327779336056220&hl=en&as_sdt=0,5
Cannabinoid therapy in practice. (Germany) (abst in German & English- 2018) https://link.springer.com/article/10.1007%2Fs00120-018-0636-0
Medical Cannabis: The Oncology Nurse’s Role in Patient Education About the Effects of Marijuana on Cancer Palliation. (USA) (abst – 2018) https://cjon.ons.org/cjon/22/1/medical-cannabis-oncology-nurse-s-role-patient-education-about-effects-marijuana-cancer
Health-related quality of life across cancer cachexia stages. (Canada) (full – 2019) http://apm.amegroups.com/article/view/21116/22353
Medical Cannabis in the Skilled Nursing Facility: A Novel Approach to Improving Symptom Management and Quality of Life. (USA) (full – 2019) https://www.jamda.com/article/S1525-8610(18)30662-5/fulltext
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence. (Poland) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406915/
Medical Cannabis Certification in a Large Pediatric Oncology Center. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617193/
Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Symptoms. (USA/ Canada) (full – 2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2018.0658?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed The use of cannabis in supportive care and treatment of brain tumor. (Austria) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655483/
An Open-Label Pilot Study Testing the Feasibility of Assessing Total Symptom Burden in Trials of Cannabinoid Medications in Palliative Care. (Australia) (full – 2019) https://www.liebertpub.com/doi/full/10.1089/jpm.2019.0540?url_ver=Z39.88-
2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed Opportunities for cannabis in supportive care in cancer. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676264/
Medical Cannabis Use in Palliative Care: Review of Clinical Effectiveness and Guidelines – An Update [Internet]. (Canada) (full – 2019) https://www.ncbi.nlm.nih.gov/books/NBK551867/
Cannabis Use among Patients in a Rural Academic Palliative Care Clinic. (USA) (full – 2019) https://www.liebertpub.com/doi/abs/10.1089/jpm.2018.0534?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88
– 2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=jpm The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review (USA) (link to PDF–2019) https://www.researchgate.net/publication/333265797_The_Potential_Benefits_of_Palmitoylethanolamide_in_Palliation_A_Qualitative_Systematic_Review
Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care. (USA) (download – 2019) Relationship of Cannabis Use to Patient-Reported Symptoms … Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review. (USA) (click “dalgarnoinstitute” for download – 2019) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Cannabis+Hyperemesis+Syndrome+in+Palliative+Care%3A+A+Case+Study+and+Narrative+Review.&btnG

Should Oncologists Recommend Cannabis? (USA) (article – 2019) https://link.springer.com/article/10.1007%2Fs11864-019-0659-9
Cannabis and cannabinoids in palliative care. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02967-1
Efficacy and safety of medicinal cannabis: results of the CaPRis study. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00103-019-02965-3
The use of cannabis-based drugs in pain and palliative medicine : Joint online questionnaire conducted by the Professional Association of Physicians and Psychotherapists in Pain and Palliative Medicine in Germany (BVSD), the German Pain Society, and the German Society for Pain Medicine (DGS). (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00482-019-00406-3
Dronabinol in geriatric pain and palliative care patients. (Germany) (abst in English & German – 2019) https://link.springer.com/article/10.1007%2Fs00482-019-00408-1
Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. (Israel) (abst – 2019) https://www.tandfonline.com/doi/abs/10.1080/13543784.2019.1561859?journalCode=ieid20
The Prevalence of Nonprescription Cannabinoid-Based Medicines in British Children’s Hospices: Results of a National Survey. (UK) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30715962
Medical Marijuana in the Pediatric Population With Epilepsy-What You Should Know. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31160106
Medical marijuana use for pediatric oncology patients: single institution experience. (Israel) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31424297
Perception of Benefits and Harms of Medical Cannabis among Seriously Ill Patients in an Outpatient Palliative Care Practice. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31539298
Effect of cannabis on opioid use in patients with cancer receiving palliative care. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S1544319119304960
Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population. (USA) (abst – 2020) https://journals.sagepub.com/doi/abs/10.1177/1049909119900378?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=ajhb
Who is asking about medicinal cannabis in palliative care? (Australia) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/32037714


PANCREAS/PANCREATITIS+
Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons. (Finland/ Italy) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423197/
Cannabinoid CB1 receptors and mTORC1 signalling pathway interact to modulate glucose homeostasis. (Spain/ France) (full – 2015) http://dmm.biologists.org/content/9/1/51.long
Role of the Endocannabinoid System in Diabetes and Diabetic Complications. (Italy/ USA) (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13226/full
Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture. (Sweden/ Poland/ Austria/ Italy) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653226/
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans. (Italy/ Netherlands) (full – 2015) http://jn.nutrition.org/content/145/9/2169.long
Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells. (Republic of Korea/ USA) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150981
Endocannabinoid regulation of β-cell functions: Implications for glycemic control and diabetes. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045244/
Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells. (China/ USA) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949433/
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo- Controlled, Parallel Group Pilot Study. (UK) (full – 2016) http://care.diabetesjournals.org/content/39/10/1777.long
GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans. (UK) (link to download – 2016) https://kclpure.kcl.ac.uk/portal/files/58649551/Liu_et_al_2016_Diabetes_Obesity_and_Metabolism.pdf
Medical use of cannabis products : Lessons to be learned from Israel and Canada. (Germany) (abst in English & German – 2016) https://link.springer.com/article/10.1007%2Fs00482-015-0083-4
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review. (Germany) (abst in English & German – 2016) https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats. (India) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S000927971530154X
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes. (Canada) (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27767974
Immunohistochemistry Detected and Localized Cannabinoid Receptor Type 2 in Bovine Fetal Pancreas at Late Gestation. (Italy) (full – 2017) http://www.ejh.it/index.php/ejh/article/view/2761/2667
Endocannabinoid system acts as a regulator of immune homeostasis in the gut. (USA) (full – 2017) http://www.pnas.org/content/early/2017/04/18/1612177114.long
Severity and outcomes of acute alcoholic pancreatitis in cannabis users. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539398/
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360301/
A TRPV1‐to‐secretagogin regulatory axis controls pancreatic β‐cell survival by modulating protein turnover. (Austria/ Sweden/ Italy/ Hungary) (full – 2017) http://emboj.embopress.org/content/early/2017/06/19/embj.201695347.long
LH-21 and Abn-CBD improve β-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling. (UK/ Spain) (link to download – 2017) https://kclpure.kcl.ac.uk/portal/files/97046207/data_proof_2.pdf
Role of cannabis in digestive disorders. (USA/ India) (abst – 2017) https://www.semanticscholar.org/paper/Role-of-cannabis-in-digestive-disorders-Goyal-
Singla/232a2b4bf1a1211f32a299f735c94c5e6a272b44 Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in those with pancreatic ductal adenocarcinoma. (Italy) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28631495
Cannabis-Induced Acute Pancreatitis: A Systematic Review. (USA) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28796137
Blockade of cannabinoid 1 receptor improves glucose responsiveness in pancreatic beta cells. (Republic of Korea/ USA) (full – 2018) http://onlinelibrary.wiley.com/doi/10.1111/jcmm.13523/full
Endocannabinoids in Body Weight Control. (Germany) (full – 2018) http://www.mdpi.com/1424-8247/11/2/55/htm
Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet- induced beta cell dysfunction and inflammation in murine islets. (USA) (full – 2018) https://link.springer.com/article/10.1007%2Fs00125-018-4576-4
Endocannabinoids in Islets of Langerhans: The Ugly, the Bad and the Good Facts. (USA) (full – 2018) https://www.physiology.org/doi/full/10.1152/ajpendo.00338.2017
Cannabinoid receptor type 1 in the brain regulates the affective component of visceral pain in mice. (Germany) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306452218303919
Is There an Effect of Cannabis Consumption on Acute Pancreatitis? (USA) (abst – 2018) https://link.springer.com/article/10.1007%2Fs10620-018-5169-2
https://www.semanticscholar.org/paper/Is-There-an-Effect-of-Cannabis-Consumption-on-Acute-Simons-Linares-Barkin/a95ef321a28f2380f437b40a73ee6fb69aad4ba9
Cannabis Use Is Associated With Increased Risk of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Analysis of the US Nationwide Inpatient Sample Database, 2004-2014. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30134357
Ximenia americana heteropolysaccharides ameliorate inflammation and visceral hypernociception in murine caerulein-induced acute pancreatitis: Involvement of CB2 receptors. (Brazil/ UK) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S075333221831970X
Novel protective effect of O-1602 and abnormal cannabidiol, GPR55 agonists, on ER stress-induced apoptosis in pancreatic β-cells. (China) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0753332218375668?via%3Dihub
Altered cannabinoid receptor expression in pancreatic islets in experimental model of uremia. (Poland) (full – 2019) https://journals.viamedica.pl/folia_morphologica/article/view/64828
“HASH”ing out pancreatitis: the new increasingly common culprit. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735343/
The Impact of Cannabis Consumption on Mortality, Morbidity, and Cost in Acute Pancreatitis Patients in the United States: A 10-Year Analysis of the National Inpatient Sample. (USA) (link to PDF – 2019) https://www.researchgate.net/publication/334141663_The_Impact_of_Cannabis_Consumption_on_Mortality_Morbidity_and_Cost_in_Acute_Pancreatitis_Patients_in_the_United_States_A_10 -Year_Analysis_of_the_National_Inpatient_Sample
Endocannabinoid Signalling in Atherosclerosis and Related Metabolic Complications. st (Germany) (1 page – 2019) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0039-1678738
Reduced Risk of Alcohol‐Induced Pancreatitis With Cannabis Use. (USA/ Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30570765


PANIC ATTACKS/PANIC
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses. (Brazil) (link to PDF – 2015) https://www.researchgate.net/publication/271334260_Role_of_endocannabinoid_signalling_in_the_dorsolateral_periaqueductal_grey_in_the_modulation_of_distinct_panic-like_responses
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1- endoccannabinoid receptor in the ventral mesencephalon. (Brazil) (abst – 2015) https://www.sciencedirect.com/science/article/pii/S001429991500268X?via%3Dihub
Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans. (USA) (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25034429
Evidences for the anti-panic actions of Cannabidiol. (Brazil) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412699/
Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack. (Brazil) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0166432816307999
https://www.semanticscholar.org/paper/Effects-of-alprazolam-and-cannabinoid-related-in-an-Batista-Haibara/132889807de95e1ebd45e07cd894cea8fcd15a39
Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks. (Brazil) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0028390819300231?via%3Dihub
Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus. (Brazil/ Pakistan) (abst – 2020) https://link.springer.com/article/10.1007%2Fs00213-019-05435-5


PARANEOPLASTIC CEREBELLAR DEGENERATION/PCD
Paraneoplastic cerebellar degeneration: Yo antibody alters mitochondrial calcium
buffering capacity (Norway – link to PDF–2018)  https://www.researchgate.net/publication/324678254_Paraneoplastic_cerebellar_degeneration_Yo_antibody_alters_mitochondrial_calcium_buffering_capacity


PARENTING/PARENTS/FAMILY
The Association of Low Parental Monitoring With Early Substance Use in European American and African American Adolescent Girls. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712655/
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646225/
Parental Separation and Early Substance Involvement: Results from Children of Alcoholic and Cannabis Dependent Twins. (USA/ UK/ Australia) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908916/
Maternal separation and early stress cause long-lasting effects on dopaminergic and endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats. (Mexico) (link to PDF – 2015) https://www.researchgate.net/publication/283511915_Maternal_separation_and_early_stress_cause_long-lasting_effects_on_dopaminergic_and_endocannabinergic_systems_and_alters_dendritic_morphology_in_the_nucleus_accumbens_an d_frontal_cortex_in_rats
Early onset of cannabis use: Does personality modify the relation with changes in perceived parental involvement? (Netherlands) (click “academia” for download – 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Early+onset+of+cannabis+use%3A+Does+personality+modify+the+relation+with+changes+in+perceived+parental+involvement%3F+++++++++++++++&btnG
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy. (USA) (abst – 2015) http://www.epilepsybehavior.com/article/S1525-5050(15)00104-3/fulltext
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869705/
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History. (Spain) (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160949
Secondary Effects of an Alcohol Prevention Program Targeting Students and/or Parents. (Netherlands) (abst – 2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30152-0/abstract
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy. (Mexico) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368357/
Phenotypic and familial associations between childhood maltreatment and cannabis initiation and problems in young adult European-American and African-American women. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599374/
Perceived injunctive norms and cannabis-related problems: The interactive influence of parental injunctive norms and race. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995670/
The Intergenerational Transmission of Cannabis Use: Associations Between Parental History of Cannabis Use and Cannabis Use Disorder, Low Positive Parenting, and Offspring Cannabis Use. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805616/
Mothering under the influence: how perinatal drugs of abuse alter the mother-infant interaction. (Italy) (link to PDF – 2017) https://www.researchgate.net/publication/321450603_Mothering_under_the_influence_How_perinatal_drugs_of_abuse_alter_the_mother-infant_interaction
Multidimensional Family Therapy Reduces Self-Reported Criminality Among Adolescents With a Cannabis Use Disorder. (Netherlands/ USA/ Switzerland) (click “mdft” for download– 2017) https://scholar.google.com/scholar?q=%22Multidimensional+Family+Therapy+Reduces+Self-Reported+Criminality+Among+Adolescents+With+a+Cannabis+Use+Disorder.%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
Family Structure and Adolescent Substance Use: An International Perspective. (USA) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28605218
Prevalence and factors associated with experience of intrafamilial violence by teenagers in school. (Brazil) (full in English, link to Portuguese – 2018) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-71672018000301022&lng=en&nrm=iso&tlng=en
Trends in Cannabis and Cigarette Use Among Parents With Children at Home: 2002 to 2015. (USA) (full – 2018) http://pediatrics.aappublications.org/content/early/2018/05/10/peds.2017-3506.long
Family management risk and protective factors for adolescent substance use in South Africa. (South Africa) (full – 2018) https://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-018-0163-4
Maternal Cannabis Use During a Child’s Lifetime Associated With Earlier Initiation. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481668/
Marijuana and Tobacco Coexposure in Hospitalized Children. (USA) (full – 2018) http://pediatrics.aappublications.org/content/142/6/e20180820.long
Parental Divorce and Family History of Alcohol Disorder: Associations with Young Adults’ Alcohol Problems, Marijuana Use, and Interpersonal Relations. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984164/
Attitudes and Risk Perceptions Toward Smoking Among Adolescents Who Modify Cigar Products. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051504/
Relative influence of perceived peer and family substance use on adolescent alcohol, cigarette, and marijuana use across middle and high school. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314679/
Poly-product drug use disparities in adolescents of lower socioeconomic status: Emerging trends in nicotine products, marijuana products, and prescription drugs. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743974/
Childhood interpersonal violence and adult alcohol, cannabis, and tobacco use disorders: variation by race/ethnicity? (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545193/
Associations of Father’s Lifetime Cannabis Use Disorder with Child’s Initiation of Cannabis Use, Alcohol Use, and Sexual Intercourse by Child Gender. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264895/
Supporting Transgender and Gender Diverse Youth: Protection Against Emotional Distress and Substance Use. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501838/
Parental Restriction of Movie Viewing Prospectively Predicts Adolescent Alcohol and Marijuana Initiation: Implications for Media Literacy Programs (USA) (link to PDF–2018) https://www.researchgate.net/publication/324895531_Parental_Restriction_of_Movie_Viewing_Prospectively_Predicts_Adolescent_Alcohol_and_Marijuana_Initiation_Implications_for_Media_Literacy_Programs
College degree attainment by age of first marijuana use and parental education. (USA) (link to PDF – 2018) https://www.researchgate.net/publication/329204455_College_degree_attainment_by_age_of_first_marijuana_use_and_parental_education
Maltreatment, attachment, and substance use in adolescence: Direct and indirect pathways. (Canada) (click “adolescenthealthca” for download – 2018) https://scholar.google.com/scholar?q=%22Maltreatment,+attachment,+and+substance+use+in+adolescence:+Direct+and+indirect+pathways%22&hl=en&as_sdt=0&as_vis=1&oi=scholart
The Continued Impact of Marijuana Legalization on Unintentional Pediatric Exposures in Colorado. (USA) (abst – 2018) http://journals.sagepub.com/doi/abs/10.1177/0009922818805206?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed https://www.semanticscholar.org/paper/The-Continued-Impact-of-Marijuana-Legalization-on-Wang-Hoyte/49ee269650bb0f31fdace49869f2da116ee7e413 Unintentional Exposure of an Infant to Synthetic Cannabinoid (Bonzai) Related to the Parent’s Use. (Turkey) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29698342
The Impact of the Urban Neighborhood Environment on Marijuana Trajectories During Emerging Adulthood. (USA) (abst – 2018) https://link.springer.com/article/10.1007/s11121-018-0915-4
Childhood trauma- and cannabis-associated microstructural white matter changes in patients with psychotic disorder: a longitudinal family-based diffusion imaging study. (Netherlands) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/29807550
Substance use and use disorders and treatment receipt among adults in families receiving Temporary Assistance for Needy Families (TANF), 2003-2014. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318301849
‘Parents are the best prevention’? Troubling assumptions in cannabis policy and prevention discourses in the context of legalization in Canada. (Canada) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0955395918301701?via%3Dihub
Perceived parental reactions to substance use among adolescent vapers compared with tobacco smokers and non-users in Iceland. (USA/ Iceland) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0033350618302634
Resilience against marijuana use initiation in low-income African American youth. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0306460318304751
Is Parent-Adolescent Drug Talk Always Protective? Testing A New Scale of Drug Talk Styles in Relation to Adolescent Personal Norms, Parental Injunctive Norms, Substance Use Intentions, and Behaviors. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30358429
The Mediating Effect of Social Controls on Marijuana Use Among Adolescent Bullies, Victims, and Bully-Victims: A Comparison of Various Approaches to Mediation. (USA) (abst – 2018) https://www.ncbi.nlm.nih.gov/pubmed/30596307
Substance use behaviors and the timing of family formation during young adulthood. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380513/
Indoor cannabis smoke and children’s health. (USA) (full – 2019) https://www.sciencedirect.com/science/article/pii/S2211335519300385?via%3Dihub

Longitudinal Associations Between the Adolescent Family Environment and Young Adult Substance Use in Australia and the United States. (Australia/ USA) (full – 2019) https://www.frontiersin.org/articles/10.3389/fpsyt.2019.00821/full
Correlates of cannabis and other illicit drugs use among secondary school adolescents in Nigeria. (Nigeria/ Italy/ Belguim) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0376871619302169?via%3Dihub
Substance Use Among Young Mothers: An Analysis of Facebook Posts. (USA) (full – 2019) https://pediatrics.jmir.org/2018/2/e10261/
Mummy, daddy, and addiction: Implicit insecure attachment is associated with substance use in college students. (France/ Belgium) (full – 2019) https://psyarxiv.com/r4wf5/
Parental Identification and Response to Adolescent Substance Use and Substance Use Disorders. (USA) (link to PDF – 2019) https://www.researchgate.net/publication/320293668_Parental_identification_and_response_to_adolescent_substance_use_and_substance_use_disorders
Genetic and Environmental Risk Factors for Cannabis Use: Preliminary Results for the Role of Parental Care Perception. (Italy/ USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30663487
Parents as interventionists: Addressing adolescent substance use. (USA) (abst – 2019) https://www.journalofsubstanceabusetreatment.com/article/S0740-5472(18)30431-8/fulltext
Exploring Cannabis-Specific Parenting as a Mechanism of the Intergenerational Transmission of Cannabis Use and Cannabis Use Disorder. (USA/ Republic of Korea) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/30807272
Parental views on state cannabis laws and marijuana use for their medically vulnerable children. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S037687161830509X?via%3Dihub
Variations in risk and promotive factors on substance use among urban American Indian youth. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31076018
Age, period and cohort effects in frequent cannabis use among US students: 1991-2018. (USA) (abst – 2019) https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14665
The impact of substance use during middle school and young adulthood on parent-young adult relationships. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31318272
Cannabis in homes with children: use and storage practices in a legalised state. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31371385
Parenting Practices in the Context of Legal Marijuana: Voices from Seattle Parents. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31396007
Parental Cannabis Use Is Associated with Cannabis Initiation and Use in Offspring. (Canada/ USA) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0022347618315646
Pathways connecting socioeconomic variables, substance abuse and gambling behaviour: a cross-sectional study on a sample of Italian high-school students. (Italy) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31719086
Child Maltreatment, Relationship with Father, Peer Substance Use, and Adolescent Marijuana Use. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31736614
Substance abuse in adolescents before admission to Peruvian juvenile detention centers: results from a national census in Peru, 2016. (Peru/ Nicaragua/ Argentina/ USA) (abst – 2019) https://www.degruyter.com/view/j/ijamh.ahead-of-print/ijamh-2019-0157/ijamh-2019-0157.xml
Risk and Protective Factors for Substance Use Among Youth Experiencing Homelessness. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31827311
Child Maltreatment, Fathers, and Adolescent Alcohol and Marijuana Use Trajectories. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31851860
Parental Cannabis Use: Contradictory Discourses in the Media, Government Publications, and the Scientific Literature. (Canada) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31589908
Intergenerational congruence in adolescent onset of alcohol, tobacco, and marijuana use. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31916782
Authoritative Parenting Behaviors and Marijuana Use Based on Age Among a National Sample of Hispanic Adolescents. (USA) (abst – 2020) https://link.springer.com/article/10.1007%2Fs10935-019-00576-x
Perceived Ease of Access and Age Attenuate the Association Between Marijuana Ad Exposure and Marijuana Use in Adolescents. (USA) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31958996


PARKINSON’S DISEASE*+
Aging & Medical Marijuana. (USA) (booklet – undated) https://www.safeaccessnow.org/aging
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson’s Disease Patients in Colorado. (USA) (full – 2015) http://www.hindawi.com/journals/ecam/2015/874849/
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control. (Italy/ UK) (full – 2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2901163-8
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. (UK/ Canada) (full – 2015) http://www.sciencedirect.com/science/article/pii/S0014488615300583
The therapeutic potential of cannabinoids for movement disorders. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357541/
Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia. (Spain) (full – 2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13215/full
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (Iran/ UK) (full – 2015) http://link.springer.com/article/10.1007%2Fs13311-015-0367-5
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications. (Spain) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. (Spain) (full – 2015) http://link.springer.com/article/10.1007/s00429-014-0823-8
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection. (Republic of Korea) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404240/
Cannabinoids for the Treatment of Movement Disorders. (USA) (link to PDF – 2015) https://www.researchgate.net/publication/280327565_Cannabinoids_for_the_Treatment_of_Movement_Disorders
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson’s disease. (Brazil) (link to PDF – 2015) https://www.researchgate.net/publication/283717163_The_neuroprotection_of_cannabidiol_against_MPP-induced_toxicity_in_PC12_cells_involves_trkA_receptors_upregulation_of_axonal_and_synaptic_proteins_neuritogenesis_and_migh t_be_relevant_to_Parkinson’s_d
The role of cannabinoids and leptin in neurological diseases. (Turkey) (link to PDF– 2015) https://www.researchgate.net/publication/287360490_The_role_of_cannabinoids_and_endocannabinoid_system_in_the_treatment_of_epilepsy
Endocannabinoids and Neurodegenerative Disorders: Parkinson’s Disease, Huntington’s Chorea, Alzheimer’s Disease, and Others. (Spain) (download – 2015) Endocannabinoids and Neurodegenerative Disorders: Parkinson’s … Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB 2 Receptors. (Spain) (click “oxoprobics” for download – 2015) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Neuroprotective+Effect+of+JZL184+in+MPP%2B-Treated+SH-
SY5Y+Cells+Through+CB+2+Receptors.++++++++&btnG Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (Spain) (abst – 2015) http://www.sciencedirect.com/science/article/pii/S0278584615000664
https://www.semanticscholar.org/paper/Potential-of-the-cannabinoid-CB(2)-receptor-as-a-in-G%C3%B3mez-G%C3%A1lvez-Palomo-Garo/cb225ea017c4fe7b80ac75ebc7cc5fc6ea3b9995
Chapter Seven – Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function. (Italy) (abst – 2015) https://www.ncbi.nlm.nih.gov/pubmed/26638769
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases. (Italy) (click “cnrit” for download – 2016) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=The+bright+side+of+psychoactive+substances%3A+cannabinoid
– based+drugs+in+motor+diseases.&btnG Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice. (Spain) (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816302663
Reversal effect of simvastatin on the decrease in cannabinoid receptor 1 density in 6- hydroxydopamine lesioned rat brains. (Australia/ China) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27155397
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation- driven rat models of Parkinson’s disease. (Ireland) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action. (Brazil) (abst – 2016) https://www.sciencedirect.com/science/article/abs/pii/S096999611630153X
Type-2 cannabinoid receptors in neurodegeneration. (Italy) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Nature of the placebo and nocebo effect in relation to functional neurologic disorders. (Italy) (abst – 2016) https://www.sciencedirect.com/science/article/pii/B9780128017722000485
Pain in Extrapyramidal Neurodegenerative Diseases. (Israel) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27623111
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage. (Mexico) (full in English – 2017) http://www.elsevier.es/en-revista-neurologia-english-edition–495-avance-resumen-effect-inhibition-fatty-acid-amide-
S2173580818301706 (full in Spanish) http://www.elsevier.es/es-revista-neurologia-295-avance-efecto-del-inhibidor-amida-hidrolasa-S0213485316302493
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target. (Italy) (full – 20 17) http://journal.frontiersin.org/article/10.3389/fnins.2017.00030/full
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson’s Disease Induced by MPTP. (Mexico/ Spain/ Switzerland) (full – 2017) http://www.mdpi.com/1424-8247/10/3/60/htm
Cannabinoids in Parkinson’s Disease. (Italy) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436333/
A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders. (Singapore) (full – 2017) http://www.cpn.or.kr/journal/view.html?volume=15&number=4&spage=301
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of Vascular Dementia. (Italy/ USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/

top

AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of DA neurons in PD mice. (China) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620217/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases . (Italy) (full – 2017) http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference. (USA/ Japan/ Brazil) (full – 2017) https://www.nature.com/articles/s41598-017-17796-y
Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases. (Italy) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984567/
Endocannabinoid System in Neurodegenerative Disorders. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669051/
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of endocannabinoid system modulation. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984569/
A natural product from Cannabis sativa subsp. sativa inhibits homeodomain-interacting protein kinase 2 (HIPK2), attenuating MPP+-induced apoptosis in human neuroblastoma SH-SY5Y cells. (China) (click “PDF Reader” for full – 2017) https://kundoc.com/pdf-a-natural-product-from-cannabis-sativa-subsp-sativa-inhibits-homeodomain-interac.html
Clinical Evidence for Utilizing Cannabinoids in the Elderly. (Israel) (link to PDF – 2017) https://www.ima.org.il/imaj/viewarticle.aspx?year=2017&month=02&page=71
Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal genes in Parkinson model rats. (Japan) (link to PDF – 2017) https://www.researchgate.net/publication/317296817_Zonisamide_ameliorates_levodopa-
induced_dyskinesia_and_reduces_expression_of_striatal_genes_in_Parkinson_model_rats Cannabis use in people with Parkinson’s disease and Multiple Sclerosis: A web-based investigation. (USA) (link to PDF – 2017) https://www.researchgate.net/publication/318332922_Cannabis_use_in_people_with_Parkinson’s_disease_and_Multiple_Sclerosis_A
_web-based_investigation GPR55: A therapeutic target for Parkinson’s disease? (Spain/ Germany) (link to PDF– 2017) https://www.researchgate.net/publication/319079347_GPR55_A_therapeutic_target_for_Parkinson’s_disease
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? (Italy/ Spain/ Germany) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28276775
Neurotransmission systems in Parkinson’s disease. (Iran) (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28328536
GPR3 and GPR6, novel molecular targets for cannabidiol. (USA) (abst – 2017) http://www.sciencedirect.com/science/article/pii/S0006291X17310744
Perspectives of Cannabinoid type 2 receptor (CB2R) ligands in neurodegenerative disorders: Structure Affinity Relationship (SAfiR) and Structure Activity Relationship (SAR) Studies. (Italy/ Albania) (abst – 2017) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b00155
Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson’s disease. (Germany) (abst – 2017) http://www.sciencedirect.com/science/article/pii/S0197018617301687
https://www.semanticscholar.org/paper/Contrasting-effects-of-selective-MAGL-and-FAAH-on-a-Pasquarelli-Porazik/d58b5b21b422a2ac852cfe10e5c78b2fc0a7f46b
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor. (Spain/. UK) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771072/
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. (Canada) (full – 2018) https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-fulltext-article-DHPS
Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders? (Brazil) (full – 2018) https://www.frontiersin.org/articles/10
.3389/fphar.2018.00482/full Evidence for the use of “medical marijuana” in psychiatric and neurologic disorders. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007658/
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. (Italy) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871676/
Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases. (Italy/ Israel) (full – 2018) http://www.mdpi.com/1420-3049/23/7/1526/htm
Comprehensive Examination of Therapies for Pain in Parkinson’s Disease: A Systematic Review and Meta-Analysis. (Canada/ Pakistan) (full – 2018) https://www.karger.com/Article/FullText/492221
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age. (Brazil) (full – 2018) https://www.frontiersin.org/articles/10.3389/fimmu.2018.02009/full
Cannabis Therapeutics and the Future of Neurology. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200872/
Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson’s Disease. (Spain) (full – 2018) https://link.springer.com/article/10.1007%2Fs13311-018-0603-x
Insight into the emerging role of striatal neurotransmitters in the pathophysiology of Parkinson’s disease and Huntington’s disease: A review. (India) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343208/
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson’s disease. (Italy) (link to PDF – 2018) https://www.researchgate.net/publication/325802100_Dopamine_D2_receptor_activation_potently_inhibits_striatal_glutamatergic_transmission_in_a_G2019S_LRRK2_genetic_model_of_Parkinson%27s_disease
GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol. (USA) (download – 2018) A study of GPR3, GPR6, of GPR12 as novel molecular targets … Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system. (Spain) (click “open access” then “Dipositubedu” for download – 2018) https://www.semanticscholar.org/paper/Cannabinoid-pharmacology%2Ftherapeutics-in-chronic-Aymerich-As%C3%B3/2e9946a36f70b0f5e320459b0f8f7a7125c72bdc
TSFM mutations cause a complex hyperkinetic movement disorder with strong relief by cannabinoids (Germany) (1ST page–2019) https://www.prd-journal.com/article/S1353
-8020(18)30427-9/fulltext Cannabis in Parkinson’s Disease: Hype or help? (Germany) (abst in German & English – 2018) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0043-120668
Identification of metabolite biomarkers for L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease by metabolomic technology. (China) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0166432817316212
https://www.semanticscholar.org/paper/Identification-of-metabolite-biomarkers-for-in-a-of-Wang-Zhang/6015ca3e3dd69296907e606eb237a52c00057c94
β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity. (China) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0753332217370269
The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia. (Spain/ France/ UK/ China) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0969996118301979
Molecular Imaging of the Cannabinoid System in Idiopathic Parkinson’s Disease. (Italy) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0074774218300692
Toxic leukoencephalopathy with extrapyramidal dysfunction due to synthetic cannabinoids. (USA) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0967586818307914
Marijuana for Parkinson’s Disease? (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450681/
Biological bases for a possible effect of cannabidiol in Parkinson’s disease. (Brazil) (full – 2019) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462019005012104&lng=en&nrm=iso&tlng=en
The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson’s disease. (China) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0278584619302210
Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia. (Australia) (full – 2019) https://www.sciencedirect.com/science/article/pii/S0969996119303213?via%3Dihub
Pros and Cons of Marijuana in Treatment of Parkinson’s Disease. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682376/
The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review. (USA) (link to PDF – 2019) https://www.researchgate.net/publication/333265797_The_Potential_Benefits_of_Palmitoylethanolamide_in_Palliation_A_Qualitative_Systematic_Review
Evidence for the use of cannabinoids in Parkinson’s disease. (Germany) (abst – 2019) https://link.springer.com/article/10.1007%2Fs00702-019-02018-8
Chapter Eight – Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders. (Spain) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0074774219300327
Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease. (Belgium) (abst – 2019) https://link.springer.com/article/10.1007%2Fs00259-019-04445-x
https://www.semanticscholar.org/paper/Regional-changes-in-the-type-1-cannabinoid-receptor-Ceccarini-Casteels/baafda061e0d91dbd321c0e8125533e94a13552b
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease. (Spain) (abst – 2019) https://link.springer.com/article/10.1007%2Fs12035-019-1495-4
The challenge of pain in the pharmacological management of Parkinson’s disease. (Germany) (abst – 2019) https://www.tandfonline.com/doi/abs/10.1080/14656566.2019.1639672?journalCode=ieop20
Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson’s Disease and L-DOPA-Induced Dyskinesia. (Brazil) (abst – 2019) https://link.springer.com/article/10.1007%2Fs12640-019-00109-8
Inhibition of tremulous jaw movements in rats by memantine-Δ9 -tetrahydrocannabinol combination: neuroanatomical correlates. (Russia) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31696510
Antinociceptive effects of treadmill exercise in a rat model of Parkinson’s disease: the role of cannabinoid and opioid receptors. (Brazil) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S000689931930575X?via%3Dihub
Potential new therapies against a toxic relationship: neuroinflammation and Parkinson’s disease. (Brazil / Spain) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31703030
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson’s disease. (Brazil) (abst – 2019) https://www.sciencedirect.com/science/article/abs/pii/S0028390819303703?via%3Dihub
Dronabinol use in France between 2004 and 2017. (France) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0035378717308019
Cannabinoids and the expanded endocannabinoid system in neurological disorders. (Italy/ Canada) (abst – 2019) https://www.nature.com/articles/s41582-019-0284-z
Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission? (Italy/ Netherlands) (full – 2020) https://www.mdpi.com/1422-0067/21/3/723/htm
Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease. (USA/ Ireland) (full – 2020) https://www.mdpi.com/1420-3049/25/3/453/htm
Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease. (Brazil) (abst – 2020) https://www.ncbi.nlm.nih.gov/pubmed/31909680


PARATONIA
Toxic leukoencephalopathy with extrapyramidal dysfunction due to synthetic  cannabinoids (USA – abst–2018)  https://www.sciencedirect.com/science/article/pii/S0967586818307914

top


PATENTS RELATED TO CANNABINOIDS*+
Fatty acid amide hydrolase inhibitors: a patent review (2009 – 2014). (Italy) (full – 2015) http://www.tandfonline.com/doi/full/10.1517/13543776.2015.1067683
A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents. (India) (full – 2015) https://docksci.com/a-comprehensive-patents-review-on-cannabinoid-1-receptor-antagonists-as-
antiobes_5a35b3c1d64ab2dbfc0f0d02.html Phytocannabinoids and cannabimimetic drugs: recent patents in central nervous system disorders. (Italy) (link to PDF – 2016) https://www.researchgate.net/publication/303378556_Phytocannabinoids_and_Cannabimimetic_Drugs_Recent_Patents_in_Central_N
ervous_System_Disorders Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update. (Spain) (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27215781
Use of cannabinoids in the treatment of degenerative skeletal muscle diseases : Application #20170304217. (USA) (full – 2017) http://www.freshpatents.com/-dt20171026ptan20170304217.php
Method for conducing concentrated cannabis oil to be stable, emulsifiable and flavorless for use in hot beverages and resulting powderized cannabis oil. (USA) (full – 2017) https://patents.google.com/patent/US10172379B2/en
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-20 17). (Italy/ USA) (abst – 2017) https://www.tandfonline.com/doi/abs/10.1080/13543776.2018.1389899?journalCode=ietp20
Cannabis and cannabinoids on treatment of inflammation: a patent review. (Brazil) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31237222
A patent update on cannabinoid receptor 1 antagonists (2015-2018). (USA) (abst – 2019) https://www.tandfonline.com/doi/abs/10.1080/13543776.2019.1597851?journalCode=ietp20


PERINATAL ASPHYXIA
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide/endocannabinoid signaling system associated to memory impairments in postweaned rats. (Spain/ Argentina) (full – 2015) http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
New horizons for newborn brain protection: enhancing endogenous neuroprotection. (UK) (full – 2015) http://fn.bmj.com/content/100/6/F541
Cannabinoids in Pediatrics. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia. (Spain/ Argentina) (click “udlcat” for download – 2018) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Palmitoylethanolamide+prevents+neuroinflammation%2C+reduces+astrogliosis+and+preserves+recognition+and+spatial+memory+following+induction+of+neonatal+anoxia-ischemia&btnG 

top


PERINATAL HYPOXIC-ISCHEMIC INJURY+
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications. (Spain) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
New horizons for newborn brain protection: enhancing endogenous neuroprotection. (UK) (full – 2015) http://fn.bmj.com/content/100/6/F541
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro. (China) (abst – 2015) http://www.sciencedirect.com/science/article/pii/S0028390815001574
Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia. (Spain) (full – 2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940392/
Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets. (Norway/ Spain) (full – 2016) https://www.nature.com/articles/pr2016149
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice. (Spain) (abst – 2016) http://www.eurekaselect.com/145822/article
Cannabinoids in Pediatrics. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473390/
Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia. (Spain/ Argentina) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC61487
19/ Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders. (Spain/ Italy) (abst – 2018) https://www.sciencedirect.com/science/article/abs/pii/S0006295218303344


PERIPHERAL NERVOUS SYSTEM
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644500/
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives. (France) (link to PDF – 2015) https://www.researchgate.net/publication/278045587_Minimizing_chemotherapy-
induced_peripheral_neuropathy_Preclinical_and_clinical_development_of_new_perspectives Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979564/
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation. (Spain/ France/ Germany) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024630/
PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase. (Brazil) (full – 2016) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.13448
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons. (UK) (link to PDF– 2016) https://spiral.imperial.ac.uk:8443/handle/10044/1/43081
Targeting brain and peripheral plasticity of the lipidome in acute kainic acid-induced epileptic seizures in mice via quantitative mass spectrometry. (Germany) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1388198116303092
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions. (Ireland) (abst – 2016) http://www.eurekaselect.com/138448/article
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system. (Germany) (full – 2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181064
Early blockade of joint inflammation with a fatty acid amide hydrolase inhibitor decreases end-stage osteoarthritis pain and peripheral neuropathy in mice. (Canada) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445456/
Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407663/
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to cannabinoid-induced effects. (Spain) (full – 2017) http://www.sciencedirect.com/science/article/pii/S0024320517306069?via%3Dihub
Acetaminophen Relieves Inflammatory Pain Through CB1 Cannabinoid Receptors in the Rostral Ventromedial Medulla. (Switzerland/ Hungary) (full – 2017) http://www.jneurosci.org/content/38/2/322.long
Peripheral inflammation alters N-arachidonoylphosphatidylethanolamine (20:4-NAPE) induced modulation of nociceptive spinal cord synaptic transmission. (Czech Republic/ UK) (link to download – 2017) https://spiral.imperial.ac.uk:8443/handle/10044/1/48351
Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor. (UK) (link to download – 2017) http://eprints.whiterose.ac.uk/113366/
Disturbances of postural sway components in cannabis users. (USA/ Australia) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0376871618303272
Neuronal preservation and reactive gliosis attenuation following neonatal sciatic nerve axotomy by a fluorinated cannabidiol derivative. (Brazil) (abst – 2018) https://www.sciencedirect.com/science/article/pii/S0028390818304830


PHANTOM LIMB SYNDROME+
MMJ vs Phantom Limb Pain. (USA) (interview – 2016) https://www.hellomd.com/health-wellness/5818cc787d130e000740091d/how-i-stopped-my-phantom-limb-pain
Mechanisms and treatment of painful neuromas. (China) (abst – 2018) https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0077/revneuro-2017-0077.xml


PHARC/POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA and CATARACT SYNDROME
Functional validation of ABHD12 mutations in the neurodegenerative disease PHARC. (Spain/ France/ Sweden/ Denmark) (link to PDF–2016) https://www.researchgate.net/publication/310785104_Functional_validation_of_ABHD12_mutations_in_the_neurodegenerative_dise ase_PHARC
Elevated Levels of Arachidonic Acid-Derived Lipids Including Prostaglandins and Endocannabinoids Are Present Throughout ABHD12 Knockout Brains: Novel Insights Into the Neurodegenerative Phenotype. (USA) (full – 2019) https://www.frontiersin.org/articles/10.3389/fnmol.2019.00142/full
A novel ABHD12 nonsense variant in Usher syndrome type 3 family with genotype- phenotype spectrum review. (China) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S0378111919303476


PHOTOBIOMODULATION/ LOW LEVEL LASAR THERAPY (LLLT)
Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway. (Brazil) (link to PDF – 2017) https://www.researchgate.net/publication/320213560_Photobiomodulation_Therapy_Improves_Acute_Inflammatory_Response_in_Mice_the_Role_of_Cannabinoid_ReceptorsATP-Sensitive_K_Channelp38-MAPK_Signalling_Pathway
Combined CB2 Receptor Agonist and Photodynamic Therapy Synergistically Inhibit Tumor Growth in Triple Negative Breast Cancer. (USA/ China) (click “researchgate” for download – 2018) https://scholar.google.com/scholar?q=Combined+CB2+Receptor+Agonist+and+Photodynamic+Therapy+Synergistically+Inhibit+Tumor+Growth+in+Triple+Negative+Breast+Cancer&hl=en&as_sdt=0&as_vis= 1&oi=scholart
Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy. (South Africa) (full – 2019) https://www.mdpi.com/1422-0067/20/19/4771/htm


PHOTOBIOMODULATION/LOW LEVEL LASAR THERAPY (LLLT) 
Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway (link to PDF–2017) https://www.researchgate.net/publication/320213560_Photobiomodulation_Therapy_Improves_Acute_Inflammatory_Response_in_Mice_the_Role_of_Cannabinoid_ReceptorsATP-Sensitive_K_Channelp38-MAPK_Signalling_Pathway


PKAN/PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION/HALLERVORDEN-SPATZ SYNDROME
Cannabis Use in Children With Pantothenate Kinase-Associated Neurodegeneration (USA) (abst–2019) https://journals.sagepub.com/doi/abs/10.1177/0883073819890516?rfr_dat=cr_pub%3Dpubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&journalCode=jcna


PLACEBO EFFECT
Cannabinoids and Epilepsy. (Brazil) (full – 2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
The placebo effect: from concepts to genes. (Australia/ Germany/ USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367890/
Placebo and nocebo effects: a complex interplay between psychological factors and neurochemical networks. (Italy) (abst – 2015) https://www.semanticscholar.org/paper/Placebo-and-nocebo-effects%3A-a-complex-interplay-and-Frisaldi-Piedimonte/fb859f8d9d5414e4f5d19f8937bc427ff87cae9a
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain from Spinal Cord Injury and Disease. (USA) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/
Placebos: Honest fakery. (UK) (article – 2016) http://www.nature.com/nature/journal/v535/n7611_supp/full/535S14a.html
Placebo effect: clinical, biological and therapeutical involvements in depression. (France) (abst in English & French – 2016) http://www.em-consulte.com/article/1033101/alertePM
Nature of the placebo and nocebo effect in relation to functional neurologic disorders. (Italy) (abst – 2016) https://www.sciencedirect.com/science/article/pii/B9780128017722000485
The Placebo Effect in Cardiology: Understanding and Using It. (UK/ Canada) (full in English, abst in French – 2017) http://www.onlinecjc.ca/article/S0828-282X(17)31036-X/fulltext
Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747994/
Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747994/
Placebo Effects of Edible Cannabis: Reported Intoxication Effects at a 30-Minute Delay. (USA) (click “researchgate” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Placebo+Effects+of+Edible+Cannabis%3A+Reported+Intoxication+Effects+at+a+30-Minute+Delay.%22&btnG
Placebo Effect. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/books/NBK513296/
The Achilles Heel of Medical Cannabis Research—Inadequate Blinding of Placebo- Controlled Trials. (USA) (abst – 2018) https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2663856?redirect=true
Placebo effects and the molecular biological components involved. (China) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738668/
OPRM1 rs1799971, COMT rs4680, and FAAH rs324420 genes interact with placebo procedures to induce hypoalgesia. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31335650
Neurotransmitter systems involved in placebo and nocebo effects in healthy participants and patients with chronic pain: a systematic review. (Denmark/ Sweden) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31453980
Incorporating methods and findings from neuroscience to better understand placebo and nocebo effects in sport. (UK/ Switzerland/ Italy/ Belgium) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31573836 


POISONING-HEAVY METAL*+
Levels of selected metals in leaves of Cannabis sativa L. cultivated in Ethiopia. (Ethiopia) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503701/
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan. (Pakistan) (abst – 2015) https://www.semanticscholar.org/paper/Phytoaccumulation-of-Heavy-Metals-in-Natural-at-the-Irshad-Ruqia/b4ff9e3274f2f42059ab81c8765a6305c06935c2
Cannabis Contaminants – sources, distribution, human toxicity and pharmacologic effects (Australia) (full – 2018) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.13695

Hemp (Marijuana) reverted Copper-induced toxic effects on the essential fatty acid profile of Labeo rohita and Cirrhinus mrigala. (Pakistan/ China) (link to PDF – 2018) https://www.researchgate.net/publication/328957738_Hemp_Marijuana_reverted_Copper-induced_toxic_effects_on_the_essential_fatty_acid_profile_of_Labeo_rohita_and_Cirrhinus_mrigala Thallium-Induced
Toxicity in Rat Brain Crude Synaptosomal/Mitochondrial Fractions is Sensitive to Anti-excitatory and Antioxidant Agents. (Mexico/ Spain) (abst – 2018) https://link.springer.com/article/10.1007%2Fs12640-017-9863-1
Cannabis Contaminants: Regulating Solvents, Microbes, and Metals in Legal Weed. (USA) (full – 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791536/
High-potency cannabis and incident psychosis: correcting the causal assumption. (3) (USA) (abst– 2019) https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30178-6/fulltext
Cannabidiol Protects Dopaminergic Neuronal Cells from Cadmium. (Italy) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31718076
Macro- and microelement content and health risk assessment of heavy metals in various herbs of Iran. (Iran) (abst – 2020) https://link.springer.com/article/10.1007%2Fs11356-020-07789-2


POISONING-ORGANOPHOSPHATE+
Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon- induced seizures. (USA) (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317231/
Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development. (USA) (full – 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580823/
Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum. (USA) (abst – 2015) http://www.sciencedirect.com/science/article/pii/S0161813X15001138
Determination of herbicides paraquat, glyphosate, and aminomethylphosphonic acid in marijuana samples by capillary electrophoresis. (Brazil) (abst – 2015) https://www.ncbi.nlm.nih.gov/pubmed/25413634
Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following Developmental Chlorpyrifos Exposure in Rats. (USA) (full – 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585048/
Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon. (USA/ South Africa) (link to PDF– 2017) https://www.researchgate.net/publication/319088396_Inhibitor_of_Endocannabinoid_Deactivation_Protects_Against_In_Vitro_and_In_Vivo_Neurotoxic_Effects_of_Paraoxon
Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in normal and high-fat fed male C57BL/6J mice. (USA) (abst – 2017) https://www.sciencedirect.com/science/article/pii/S0041008X17304295?via%3Dihub
https://www.semanticscholar.org/paper/Effects-of-acute-exposure-to-chlorpyrifos-on-and-in-Kondakala-Lee/a44b323d912a068f81ccd944b6a6f0ddcf9183fa
Ajulemic acid: potential treatment for chronic inflammation. (USA) (full – 2018) https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1002/prp2.394
Inhibition of cholinergic and non-cholinergic targets following subacute exposure to chlorpyrifos in normal and high fat fed male C57BL/6J mice. (USA) (full – 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534279/
Adverse outcome pathway of developmental neurotoxicity resulting from prenatal exposures to cannabis contaminated with organophosphate pesticide residues. (USA) (link to PDF – 2019) https://www.researchgate.net/publication/330504784_Adverse_outcome_pathway_of_developmental_neurotoxicity_resulting_from_prenatal_exposures_to_cannabis_contaminated_with_organophosphate_pesticide_residues
Retrograde activation of CB1R by muscarinic receptors protects against central organophosphorus toxicity. (USA) (abst – 2019) https://www.sciencedirect.com/science/article/pii/S002839081930190X?via%3Dihub
Inhibition of fatty acid amide hydrolase by chlorpyrifos in juvenile rats results in altered exploratory and social behavior as adolescents. (USA) (abst – 2020) https://www.sciencedirect.com/science/article/abs/pii/S0161813X20300103
Organophosphate Agent Induces ADHD-Like Behaviors via Inhibition of Brain Endocannabinoid-Hydrolyzing Enzyme(s) in Adolescent Male Rats. (Japan) (abst – 2020) https://pubs.acs.org/doi/10.1021/acs.jafc.9b08195
top


POISONING-OTHER
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway. (China) (full – 2015) http://toxsci.oxfordjournals.org/content/147/2/535.long
Eagle 20 and Myclobutanil in the Context of Cannabis cultivation and Consumption. (USA) (article – 2015) http://www.coloradogreenlab.com/blog/eagle-20-and-myclobutanil-in-the-context-of-cannabis-cultivation-and-consumption
Endogenous synthesis of pyrethrins by cannabis. (Not all strains, just “Medihaze”, so far.- GSC) (USA) (link to PDF – 2017) http://www.biorxiv.org/content/early/2017/07/28/169417
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain. (China) (click “jescaccn” for download – 2017) https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=%22Endocannabinoid+2-arachidonoylglycerol+protects+inflammatory+insults+from+sulfur+dioxide+inhalation+via+cannabinoid+receptors+in+the+brain.%2 2&btnG
URB597 reduces biochemical, behavioral and morphological alterations in two neurotoxic models in rats. (Mexico) (abst – 2017) https://www.semanticscholar.org/paper/URB597-reduces-biochemical%2C-behavioral-and-in-two-Maya-L%C3%B3pez-Ruiz-Contreras/87077df2c67e814deb83762ccf6e72e14dc23f28
Grass is not always greener: rodenticide exposure of a threatened species near marijuana growing operations. (USA) (full – 2018) https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-018-3206-z
The Cannabinoid WIN 55,212-2 Reduces Delayed Neurologic Sequelae After Carbon Monoxide Poisoning by Promoting Microglial M2 Polarization Through ST2 Signaling. (China) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31732924
Evaluation of Pesticides Found in Oregon Cannabis from 2016 to 2017. (USA) (abst – 2019) https://www.ncbi.nlm.nih.gov/pubmed/31621879
High-potency cannabis and incident psychosis: correcting the causal assumption. (3) (USA) (abst– 2019) https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(19)30178-6/fulltext


POISONING–PARAQUAT*+
Determination of herbicides paraquat, glyphosate, and aminomethylphosphonic acid in marijuana samples by capillary electrophoresis (Brazil – abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/25413634


POISONING–ROTENONE
The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats. (Egypt) (click “academia” for download – 2015) https://scholar.google.com/scholar?q=%22The+effect+of+cannabis+on+oxidative+stress+and+neurodegeneration+induced+by+intrast
riatal+rotenone+injection+in+rats%22&hl=en&as_sdt=0&as_vis=1&oi=scholart Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease. (United Arab Emirates) (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation- driven rat models of Parkinson’s disease. (Ireland) (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
top


Updated 28 March 2020